Follow-up care involving plastic surgery

Z21_FOLLOW__CARE_INVOLVI_PLASTIC_SURGE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Z42 Cause of death: ICD-10 — Z42 2 out of 7 registries used, show all original rules.	1711
4. Check minimum number of events None	1711
5. Include endpoints None	1711
6. Filter based on genotype QC (FinnGen only)	1553

Control definitions (FinnGen only)

Control exclude: Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_SPECIFIC_PROCED_HEALTH_CARE

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: Z4|Z5[0-4]

NAME	Z21_FOLLOW__CARE_INVOLVI_PLASTIC_SURGE
CONTROL_EXCLUDE	Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_SPECIFIC_PROCED_HEALTH_CARE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Z42
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Z42
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Follow-up care involving plastic surgery based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1553	1264	289
Unadjusted period prevalence (%)	0.39	0.45	0.13
Median age at first event (years)	54.43	52.91	61.06

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1609: Matched controls
16090

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

HA1AA

NOMESCO Finland

X-ray mammography

8.9

307.7

577

954

HAE99

NOMESCO Finland

Other reconstruction of breast

57.2

307.7

235

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

48.5

307.7

320

ZZF00

NOMESCO Finland

Graft of adipose tissue

52.6

307.7

211

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

48.7

307.7

364

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

55.1

307.7

207

TQW20

NOMESCO Finland

Tatoe

40.4

307.7

250

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

10.6

307.7

584

822

Z42.1

ICD-10 Finland

Follow-up care involving plastic surgery of breast

+∞

307.7

914

HAC20

NOMESCO Finland

Total mastectomy

13.3

307.7

351

331

HAD30

NOMESCO Finland

Reduction mammoplasty with transposition of areola

13.6

307.7

397

378

115

Kela drug reimbursment

Breast cancer

7.8

299.1

522

935

ZZR10

NOMESCO Finland

Flap of skin and muscle

46.9

290.7

172

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

19.8

280.5

226

132

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

63.0

277.1

154

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

9.0

276.0

393

556

HAE00

NOMESCO Finland

Reconstruction of breast using prosthesis

66.1

272.3

150

QBE30

NOMESCO Finland

Excision and repair of surgical scar in trunk

52.0

261.6

151

HAD50

NOMESCO Finland

Removal of prosthetic implant from breast

53.0

252.4

145

HAD60

NOMESCO Finland

Replacement of prosthetic implant in breast

114.8

248.6

127

Z42.0

ICD-10 Finland

Follow-up care involving plastic surgery of head and neck

+∞

247.4

231

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

10.4

225.6

273

311

Z42.4

ICD-10 Finland

Follow-up care involving plastic surgery of lower extremity

+∞

222.2

208

PJA12

NOMESCO Finland

Sentinel node biopsy

6.4

221.7

447

906

ZZA00

NOMESCO Finland

Split skin graft

15.1

217.8

201

151

L02BA01

ATC

tamoxifen; oral

8.7

205.3

286

388

Z42.2

ICD-10 Finland

Follow-up care involving plastic surgery of other parts of trunk

+∞

198.1

186

HAD40

NOMESCO Finland

Mastopexy

43.7

190.3

114

QBJ00

NOMESCO Finland

Liposuction in trunk

39.5

185.4

114

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

8.1

184.8

272

392

N62

ICD-10 Finland

Hypertrophy of breast

7.8

181.1

278

420

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

13.3

173.2

171

143

C50

ICD-10 Finland

Malignant neoplasm of breast

10.1

160.4

192

213

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

10.9

160.1

180

183

C50.99

ICD-10 Finland

Breast, unspecified

9.5

159.8

201

238

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

21.2

157.3

120

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

11.7

152.3

163

154

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

13.1

148.5

147

123

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

14.3

147.5

138

105

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

11.0

146.5

163

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

40.9

146.3

H02AB02

ATC

dexamethasone; systemic

4.9

142.8

377

944

A03FA01

ATC

metoclopramide; systemic, rectal

3.8

138.8

618

2267

X76

ICPC

Malignant neoplasm breast female

10.8

131.5

148

150

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.5

129.5

1014

5250

HAC10

NOMESCO Finland

Subcutaneous mastectomy with preservation of mamilla

53.0

123.9

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

8.6

121.8

164

210

HAD99

NOMESCO Finland

Other plastic operation on breast

20.7

120.0

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

5.2

119.0

278

623

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

6.0

118.6

229

432

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

7.8

115.7

170

241

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5.6

115.0

243

498

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

8.0

112.7

160

218

WX408

NOMESCO Finland

General anesthesy, balanced

3.3

110.3

608

2494

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

4.1

102.1

331

954

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

4.9

100.7

246

569

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.0

99.0

801

4032

Z51.5

ICD-10 Finland

Palliative care

13.2

98.1

Z42.3

ICD-10 Finland

Follow-up care involving plastic surgery of upper extremity

+∞

97.9

Z31.5

ICD-10 Finland

Genetic counselling

5.1

95.2

220

485

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

10.5

95.0

107

108

HA1CM

NOMESCO Finland

Mammary gland extensive MRI examination with 3 Tesla magnet

42.2

94.5

T85.4

ICD-10 Finland

Mechanical complication of breast prosthesis and implant

38.6

90.8

Z40.0

ICD-10 Finland

Prophylactic surgery for risk-factors related to malignant neoplasms

928.9

90.7

ZZR00

NOMESCO Finland

Flap of skin

9.7

89.9

108

119

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

917.7

89.6

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

10.5

87.7

100

HAD10

NOMESCO Finland

Augmentation of breast using prosthesis

34.1

87.7

NK6AN

NOMESCO Finland

Total body bone isotope imaging

7.9

87.0

123

166

Z00.0

ICD-10 Finland

General medical examination

3.1

86.2

473

1894

Z04.3

ICD-10 Finland

Examination and observation following other accident

9.9

85.9

101

108

A04AA01

ATC

ondansetron; systemic, rectal

4.4

84.9

239

616

L03AA13

ATC

pegfilgrastim; parenteral

5.6

82.5

168

330

J01MA12

ATC

levofloxacin; systemic

3.2

81.6

418

1603

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

9.7

81.1

106

L02BG04

ATC

letrozole; oral

4.0

80.9

260

738

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.9

80.5

500

2136

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

4.6

80.0

208

503

QDE35

NOMESCO Finland

Repair of skin defect in lower limb after surgery or injury

31.6

79.6

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

9.9

79.3

JN4BD

NOMESCO Finland

Extensive body CT

4.0

79.1

251

705

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

3.3

79.1

361

1290

N64.9

ICD-10 Finland

Disorder of breast, unspecified

10.4

76.9

N02AA05

ATC

oxycodone; systemic

3.3

76.8

343

1208

ZSH00

NOMESCO Finland

Procedure related to previous procedure classified in chapter H

13.7

76.3

Z42.9

ICD-10 Finland

Follow-up care involving plastic surgery, unspecified

+∞

75.6

HWH99

NOMESCO Finland

Other reoperation in surgery of mammary gland

21.9

71.1

TQW99

NOMESCO Finland

Other minor procedure on skin

4.9

70.5

164

361

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.5

70.3

285

941

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

15.8

70.3

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

5.3

69.2

148

303

L91.0

ICD-10 Finland

Hypertrophic scar

10.1

68.5

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

6.4

67.3

115

190

QB2S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in chest

14.8

66.7

A04AA02

ATC

granisetron; systemic, transdermal

4.4

66.0

178

441

L02BG03

ATC

anastrozole; oral

8.3

64.8

110

TQB05

NOMESCO Finland

Puncture of skin of trunk

12.3

64.6

S18

ICPC

Laceration/cut

2.4

64.5

913

5657

J01DB01

ATC

cefalexin; oral

4.3

64.3

1475

11596

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

6.5

63.6

107

174

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

17.1

63.6

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

6.8

63.5

102

158

HAB99

NOMESCO Finland

Other partial excision of mammary gland

6.2

63.0

111

189

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

9.0

62.8

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

19.8

61.7

HAD20

NOMESCO Finland

Liposuction of breast

87.4

60.4

L90.5

ICD-10 Finland

Scar conditions and fibrosis of skin

10.5

60.2

HA1BA

NOMESCO Finland

Extensive X-ray mammography

17.2

60.1

B01AB05

ATC

enoxaparin; parenteral

2.4

59.3

621

3340

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.9

59.2

330

1305

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

3.0

59.0

300

1127

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

17.6

58.5

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

4.1

57.1

169

448

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

7.8

56.8

107

HAB40

NOMESCO Finland

Wedge excision of mammary gland

3.7

56.8

194

569

H25.8

ICD-10 Finland

Other senile cataract

3.3

56.3

242

823

J01FF01

ATC

clindamycin; systemic

2.4

56.0

555

2898

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

6.8

55.8

140

PJW99

NOMESCO Finland

Other operation on lymphatic system

15.3

55.5

HWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of mammary gland

14.7

55.5

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

4.9

55.4

128

279

N64.8

ICD-10 Finland

Other specified disorders of breast

12.7

54.9

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

14.8

54.6

JN4CD

NOMESCO Finland

Very extensive body CT

5.9

54.5

102

184

TQW11

NOMESCO Finland

Vacuum treatment of wound

7.5

53.7

108

SPAT1149

SPAT

Suture or treatment of traumatic wound

3.1

53.5

259

943

L02BG06

ATC

exemestane; oral

7.0

53.4

124

SPAT1153

SPAT

Removal of sutures

2.3

52.3

611

3405

TQW40

NOMESCO Finland

Remowal of suture of skin

3.6

52.1

185

556

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

8.5

52.0

SPAT1172

SPAT

Guidance concerning hydration

8.4

51.5

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

11.1

51.5

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

7.0

50.8

118

HWD00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of mammary gland

11.4

50.4

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

6.9

50.0

120

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

4.7

49.0

118

266

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

8.6

48.6

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

3.8

48.6

156

437

HA1BG

NOMESCO Finland

MRI examination of mammary gland with high intensity magnet

8.0

47.4

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5.1

47.4

102

209

S97

ICPC

Chronic ulcer skin

3.9

47.1

145

394

A04AD12

ATC

aprepitant; systemic

6.2

46.5

136

SPAT1215

SPAT

Assessment of need for medical rehabilitation

4.4

46.3

122

295

HA2AT

NOMESCO Finland

Cytology of mammary gland with ultrasound guidance

16.6

46.2

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.8

46.1

270

1086

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

7.1

46.0

102

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.4

45.6

378

1800

SPAT1211

SPAT

Application of soft bandage

3.1

45.2

204

710

Z97.4

ICD-10 Finland

Presence of external hearing-aid

8.3

45.0

JN4AD

NOMESCO Finland

Body CT examination

3.0

44.5

219

801

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

13.4

44.4

ZXE30

NOMESCO Finland

More than five and less than seven hours

4.5

43.9

112

264

N03AX16

ATC

[U] pregabalin

2.3

43.3

444

2312

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

9.9

43.2

Z42.8

ICD-10 Finland

Follow-up care involving plastic surgery of other body part

+∞

42.9

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

5.2

42.4

182

ZXE40

NOMESCO Finland

More than seven and less than nine hours

6.6

40.7

103

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

7.9

40.5

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

6.9

40.5

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.9

40.4

208

778

X21

ICPC

Breast sympt/compl female other

5.0

40.3

190

PD1AD

NOMESCO Finland

CT of abdominal aorta and branches

12.4

40.3

N02AX02

ATC

tramadol; systemic, rectal

2.0

40.0

747

4850

X59

ICD-10 Finland

Exposure to unspecified factor

2.3

39.9

356

1741

ZSZ10

NOMESCO Finland

Secondary repair operation

53.7

39.7

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.6

39.6

272

1180

WZC00

NOMESCO Finland

Treatment plan or consultation

2.0

39.5

662

4133

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

4.8

39.4

202

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.8

39.1

199

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

6.0

39.0

121

HA3AT

NOMESCO Finland

Pucture of mammary gland cyst with ultrasound examination

9.8

38.7

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

6.7

38.5

L02AE03

ATC

goserelin; implant

7.9

38.4

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

3.9

38.3

119

325

SPAT1229

SPAT

Assessment of need for aid

3.3

38.2

154

499

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

4.7

38.2

203

A87

ICPC

Complication of medical treatment

11.7

37.9

N02BE01

ATC

paracetamol; systemic, rectal

3.8

37.4

1517

13106

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

3.8

37.4

120

335

SPAT1216

SPAT

Assessment of functional ability

2.5

37.0

275

1235

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

5.8

36.9

124

ZXD05

NOMESCO Finland

Urgent procedure

2.0

36.8

530

3115

X58

ICD-10 Finland

Exposure to other specified factors

2.4

36.8

298

1391

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

13.2

36.6

N06AX16

ATC

venlafaxine; oral

2.3

36.3

311

1489

N63

ICD-10 Finland

Unspecified lump in breast

2.8

36.2

195

746

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

10.5

36.1

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

35.8

729

4821

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.8

35.4

191

731

A04AA55

ATC

palonosetron, combinations; systemic

3.6

35.2

121

354

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

2.9

35.0

184

694

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

7.9

35.0

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

6.0

34.9

106

S77

ICPC

Malignant neoplasm of skin

8.5

34.8

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

4.9

34.6

162

ZSN00

NOMESCO Finland

Procedure related to previous procedure classified in chapter N

11.9

34.4

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.6

34.0

231

992

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

6.1

34.0

102

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

4.6

33.2

184

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.0

33.0

154

544

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

4.9

32.9

157

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

4.3

32.9

215

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.9

32.9

264

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

5.3

32.8

131

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

13.2

32.3

PJ1AN

NOMESCO Finland

Lymphsystem isotope imaging

41.0

32.2

CS494

NOMESCO Finland

Other visual field testing

4.5

32.1

185

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.8

32.0

178

691

A02BC02

ATC

pantoprazole; systemic

2.0

31.8

1167

9203

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

31.6

518

3155

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

3.0

31.3

150

537

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

9.2

31.3

Z54.0

ICD-10 Finland

Convalescence following surgery

9.2

31.3

C03CA01

ATC

furosemide; systemic

2.0

31.3

423

2409

E0000UV, ,

ATC

1.8

31.0

746

5132

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

4.1

31.0

216

NF1AA

NOMESCO Finland

Hip X-ray examination

2.7

31.0

183

733

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

3.3

30.9

124

400

ZZS55

NOMESCO Finland

Distension of tissue expander

163.1

30.8

HAD55

NOMESCO Finland

Incision of periprosthetic capsule of breast

112.3

30.8

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

5.2

30.6

124

HAD57

NOMESCO Finland

Resection of periprosthetic capsule of breast

69.3

30.0

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

7.9

29.9

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

4.0

29.6

228

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.8

29.6

903

6645

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.3

29.3

260

1255

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

5.8

28.8

R60.0

ICD-10 Finland

Localized oedema

2.3

28.7

239

1122

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

3.3

28.7

112

355

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.8

28.6

154

587

NG2AA

NOMESCO Finland

Patella X-ray examination

4.0

28.6

211

A46

ICD-10 Finland

Erysipelas

2.3

28.3

242

1148

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

5.9

28.1

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.9

28.1

136

489

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

10.9

27.8

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

6.6

27.8

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

3.7

27.7

258

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.0

27.7

376

2133

SPAT1234

SPAT

Support of social functional capacity

3.4

27.2

101

310

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

4.6

27.0

146

SPAT1263

SPAT

Sampling

1.8

26.8

680

4692

QBJ30

NOMESCO Finland

Correction of abdominal apron

7.2

26.8

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

7.2

26.8

R50.9

ICD-10 Finland

Fever, unspecified

2.2

26.8

256

1271

L89

ICD-10 Finland

Decubitus ulcer and pressure area

6.3

26.2

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.4

26.2

195

870

ZXA10

NOMESCO Finland

Bilateral

2.0

26.1

322

1760

N05BA04

ATC

oxazepam; oral

1.9

26.0

467

2897

WX100

NOMESCO Finland

Conjunctival surface anesthesia

2.3

25.9

227

1086

N05CF01

ATC

zopiclone; oral

1.8

25.9

539

3498

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

3.1

25.8

110

368

JN3AD

NOMESCO Finland

Abdominal CT examination

2.3

25.6

226

1085

8500/3-C50.5

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast

7.9

25.6

JN6AD

NOMESCO Finland

CT of torso and neck

5.5

25.5

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

6.3

25.4

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

3.2

25.4

102

329

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

2.8

25.3

137

523

HAD00

NOMESCO Finland

Augmentation mammoplasty

50.9

25.3

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

3.7

25.2

226

N64.5

ICD-10 Finland

Other signs and symptoms in breast

3.5

25.1

270

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

4.8

24.9

123

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

10.2

24.8

AA1AD

NOMESCO Finland

CT of head and brain

1.8

24.7

447

2772

L28

ICPC

Limited function/disability (L)

2.0

24.7

310

1702

DAX08

NOMESCO Finland

Fitting of hearing aid

3.4

24.7

273

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

4.8

24.4

121

WF049

NOMESCO Finland

Radiotherapy of metastasis

5.1

24.3

102

UJF30

NOMESCO Finland

Ileoscopy through colon

2.3

24.3

209

992

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

7.7

24.3

SPAT1254

SPAT

Administration of medicine

2.2

24.2

223

1089

NG4AA

NOMESCO Finland

Lower leg X-ray examination

3.8

24.0

205

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.1

24.0

281

1503

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.4

24.0

178

792

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

5.0

23.5

105

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

23.5

729

5263

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

8.9

23.3

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.3

23.3

187

861

N06AX11

ATC

mirtazapine; oral

1.7

23.2

583

3970

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.8

23.0

479

3088

QAE20

NOMESCO Finland

Excision and repair of scar or web of skin of head or neck

20.4

23.0

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

4.3

22.8

145

ZZR30

NOMESCO Finland

Flap of muscle

40.7

22.7

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

4.0

22.6

163

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

4.8

22.5

109

SPAT1231

SPAT

Assessment of adjustments needed in living environment

5.8

22.5

QBG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of trunk

52.8

22.1

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

7.4

22.1

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

5.0

21.9

D48.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue

4.4

21.7

129

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.1

21.7

228

1170

SPAT1167

SPAT

Insertion of urinary catheter

4.5

21.4

118

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.8

21.3

401

2503

A02BC05

ATC

esomeprazole; systemic

1.7

21.3

690

5001

WX882

NOMESCO Finland

High dependency care

4.6

21.1

111

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.3

21.0

169

778

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.3

20.9

161

727

ACC19

NOMESCO Finland

Transcision of peripheral nerve: other or unspecified

6.7

20.9

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

+∞

20.9

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

5.8

20.8

ZSZ00

NOMESCO Finland

Primary repair operation

77.9

20.7

ZX120

NOMESCO Finland

Intravenous

2.4

20.6

149

654

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

20.6

483

3204

A08

ICPC

Swelling

2.7

20.6

114

440

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

7.3

20.4

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

5.3

20.4

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

2.1

20.2

199

994

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

4.5

20.2

115

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.1

20.1

203

1024

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

4.7

19.9

100

NH1AD

NOMESCO Finland

Ankle and foot CT

4.3

19.9

125

XG410

NOMESCO Finland

Flow-volume spirometry

3.4

19.7

224

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.0

19.7

319

ZZS10

NOMESCO Finland

Transposition flap

202.4

19.6

ZX112

NOMESCO Finland

Subcutaneous

4.3

19.6

118

T81.9

ICD-10 Finland

Unspecified complication of procedure

4.2

19.5

127

N06AB04

ATC

citalopram; systemic

1.8

19.4

360

2228

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.0

19.2

312

L03AA14

ATC

lipegfilgrastim; parenteral

4.0

19.2

137

HAB00

NOMESCO Finland

Excision of lesion of mammary gland

3.2

19.2

248

PD1BD

NOMESCO Finland

Extensive CT of abdominal aorta and branches

7.6

19.1

NJ3NA

NOMESCO Finland

Measurement of difference in extremity lengty with X-ray

5.0

19.0

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

19.0

530

3667

GD1AD

NOMESCO Finland

Thorax CT examination

2.6

19.0

112

446

M05BX04

ATC

denosumab; parenteral

2.6

18.9

113

453

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.2

18.9

175

853

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.6

18.7

117

480

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

18.7

606

4353

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

6.1

18.6

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

2.2

18.6

162

770

SPAT1310

SPAT

Counselling related to known health issue

1.7

18.6

504

3459

M05BA04

ATC

alendronic acid; oral

2.2

18.4

160

760

ZZS00

NOMESCO Finland

Rotation flap

30.4

18.4

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.7

18.3

165

M01AE02

ATC

naproxen; oral, rectal

1.6

18.3

946

7580

L02BA03

ATC

fulvestrant; parenteral

13.7

18.3

Z80.4

ICD-10 Finland

Family history of malignant neoplasm of genital organs

17.8

18.3

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

7.2

18.3

J37.0

ICD-10 Finland

Chronic laryngitis

3.1

18.2

246

QBA10

NOMESCO Finland

Incision of skin of trunk

6.2

18.1

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.9

18.1

323

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

3.3

17.9

217

Z51.0

ICD-10 Finland

Radiotherapy session

+∞

17.7

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.3

17.6

136

614

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

5.2

17.5

J01MA02

ATC

ciprofloxacin; systemic

1.6

17.5

575

4129

NK1AT

NOMESCO Finland

Muscle biopsy with ultrasound guidance

29.1

17.4

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

4.9

17.4

WW200, ,

SPAT

1.6

17.3

527

3712

H02AB07

ATC

prednisone; oral

1.9

17.2

224

1235

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

17.2

629

4625

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

17.2

372

2397

E000001, ,

ATC

1.8

17.1

332

2073

XF640, ,

NOMESCO Finland

3.9

17.1

131

Z41.1

ICD-10 Finland

Other plastic surgery for unacceptable cosmetic appearance

31.8

17.0

H02AB04

ATC

methylprednisolone; systemic

1.9

16.8

254

1470

SPAT1151

SPAT

Treatment of major wounds

6.3

16.8

J01DA01

ATC

[U] cefalexin

1.6

16.7

997

8181

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

5.0

16.7

ZZS50

NOMESCO Finland

Insertion of tissue expander

91.0

16.6

L01BC06

ATC

capecitabine; oral

3.1

16.5

228

QWF00

NOMESCO Finland

Reoperation for insufficiency of suture in plastic surgery of skin

171.7

16.5

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

5.6

16.5

SPAT1125

SPAT

Stoma care and guidance

5.6

16.5

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

2.4

16.5

122

541

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.6

16.4

399

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.8

16.4

300

WX320

NOMESCO Finland

Spinalanesthesy

1.7

16.4

398

2641

Y83.4

ICD-10 Finland

Other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

30.4

16.1

Z50.1

ICD-10 Finland

Other physical therapy

5.2

16.0

L03AA02

ATC

filgrastim; parenteral

3.4

15.8

167

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

3.4

15.8

167

R32

ICD-10 Finland

Unspecified urinary incontinence

3.3

15.8

182

HAC25

NOMESCO Finland

Radical mastectomy

13.1

15.7

ZXA05

NOMESCO Finland

Left side

1.7

15.5

353

2297

S76

ICPC

Skin infection other

2.5

15.4

387

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

12.5

15.4

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.8

15.3

277

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

6.8

15.3

C50.50

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication

16.2

15.2

XX3DW

NOMESCO Finland

Time consuming IT work

2.0

15.0

175

928

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

14.9

144

713

Z89.5

ICD-10 Finland

Acquired absence of leg at or below knee

57.2

14.8

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

2.0

14.7

159

820

NH2AA

NOMESCO Finland

Heel X-ray examination

13.3

14.7

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

3.1

14.7

201

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

3.0

14.7

217

9729

FHL

Other measure in this category

21.3

14.7

Z49.1

ICD-10 Finland

Extracorporeal dialysis

+∞

14.6

WZA90

NOMESCO Finland

Other medical or dental certificate

1.6

14.5

376

2527

QDJ00

NOMESCO Finland

Liposuction in lower extremity

36.4

14.4

9725

FHL

Reconstruction of the mammary gland with foreign material (after removal)

36.4

14.4

ZXE20

NOMESCO Finland

More than three and less than five hours

1.9

14.4

187

1028

192

Kela drug reimbursment

Fulvestrant

15.5

14.4

I78.1

ICD-10 Finland

Naevus, non-neoplastic

3.2

14.3

178

NHQ40

NOMESCO Finland

Amputation of toe

5.6

14.3

WX722

NOMESCO Finland

PEEP

2.8

14.3

276

1CD02, ,

NOMESCO Finland

4.7

14.3

C50.12

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,lobular tumor

10.5

14.2

QWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of skin

13.5

14.2

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.0

14.2

168

895

ZZA50

NOMESCO Finland

Full thickness skin graft

14.6

14.1

D70.82

ICD-10 Finland

Drug-induced neutropenia

4.5

14.0

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

2.0

14.0

163

863

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

11.0

14.0

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

10.2

14.0

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

4.3

13.9

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.8

13.7

109

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.1

13.7

126

612

N05CF02

ATC

zolpidem; oral

1.7

13.6

301

1938

QWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of skin

14.8

13.6

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

5.9

13.5

J01CA08

ATC

pivmecillinam; oral

1.5

13.5

763

6069

HA1DM

NOMESCO Finland

Mammary gland very extensive MRI examination with 3 Tesla magnet

34.3

13.5

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.4

13.5

387

X26

ICPC

Fear of breast cancer female

5.6

13.4

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

13.4

205

1189

FM1FN

NOMESCO Finland

Heart function isotope examination

6.4

13.3

H02.3

ICD-10 Finland

Blepharochalasis

2.1

13.3

126

619

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

5.4

13.3

WZC30

NOMESCO Finland

Teaching

1.7

13.2

245

1503

N06AA09

ATC

amitriptyline; systemic

2.0

13.2

157

838

J02AC01

ATC

fluconazole; systemic

1.5

13.2

720

5680

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.6

13.2

376

2579

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

4.5

13.1

A79

ICPC

Malignancy NOS

4.8

13.1

NK4EA

NOMESCO Finland

Joint X-ray examintion with load or wrench not elsewhere classified

5.5

13.1

ZXA00

NOMESCO Finland

Right side

1.6

13.0

374

2568

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.2

13.0

106

490

QDE20

NOMESCO Finland

Excision and repair of scar or web of skin of lower limb

16.9

13.0

UKC02

NOMESCO Finland

Cystoscopy

1.8

12.9

193

1110

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

12.9

670

5225

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.9

12.9

184

1043

PJA10

NOMESCO Finland

Exploration of lymph nodes

4.7

12.8

HA1RA

NOMESCO Finland

Combined assessment of mammary gland (mammography and ultrasound)

2.6

12.8

286

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

11.6

12.8

B29

ICPC

Lymph/immune mech sympt/complt other

11.6

12.8

D48.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Breast

3.2

12.8

159

J01EA01

ATC

trimethoprim; systemic

1.5

12.8

440

3147

J01MA01

ATC

ofloxacin; systemic

2.1

12.8

131

663

R52.2

ICD-10 Finland

Other chronic pain

2.6

12.8

293

HA1HA

NOMESCO Finland

Tomosynthesis mammography

5.0

12.6

130

Kela drug reimbursment

Malignant tumour

2.3

12.6

418

Q83.8

ICD-10 Finland

Other congenital malformations of breast

15.6

12.6

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

12.4

12.6

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

12.4

12.6

WF003

NOMESCO Finland

Adjuvant radiotherapy

2.7

12.6

248

ND1AA

NOMESCO Finland

Wrist X-ray examination

2.0

12.6

131

667

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.9

12.5

210

QCJ00

NOMESCO Finland

Liposuction in upper limb

20.2

12.5

ZSQ00

NOMESCO Finland

Procedure related to previous procedure classified in chapter Q

131.0

12.4

Z49.0

ICD-10 Finland

Preparatory care for dialysis

131.0

12.4

SPAT1360

SPAT

Extensive global examination

2.2

12.4

112

539

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

12.4

713

5659

Z01.2

ICD-10 Finland

Dental examination

1.5

12.4

758

6090

M03BX02

ATC

tizanidine; oral

1.5

12.3

1018

8662

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.4

12.3

391

NK6BN

NOMESCO Finland

Bone dynamic isotope examination

14.4

12.3

9703

FHL

Breast resection

5.2

12.2

ZXD40

NOMESCO Finland

Procedure on patient requiring isolation

16.0

12.1

SPAT1152

SPAT

Removal of foreign body from under the skin

3.0

12.1

175

-48

ICPC

Clarification/discussion RFE/demand

3.3

12.1

139

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

8.7

12.0

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

3.0

12.0

171

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

13.5

11.9

CBB20

NOMESCO Finland

Correction of lax skin of eyelid and resection of herniated fat

3.9

11.8

L57.0

ICD-10 Finland

Actinic keratosis

1.9

11.8

161

898

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.1

11.8

116

577

M01AE01

ATC

ibuprofen; systemic, rectal

1.9

11.7

1459

13514

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

3.0

11.7

173

D82

ICPC

Teeth/gum disease

1.5

11.7

611

4747

K03.66

ICD-10 Finland

Tooth plaque

2.0

11.6

125

643

TQX05

NOMESCO Finland

Skin puncture, unspecified location

12.6

11.6

C50.93

ICD-10 Finland

Malignant tumor in other specified localization in mammary gland other or unspecified histology

12.6

11.6

N05CD07

ATC

temazepam; oral

1.9

11.6

164

926

C43.53

ICD-10 Finland

Malignant melanoma of the torso nodular

19.1

11.6

QBE35

NOMESCO Finland

Repair of skin defect in trunk after surgery or injury

23.1

11.6

QXB05

NOMESCO Finland

Skin wound assessment, unspecified location

11.2

11.5

Z04

ICD-10 Finland

Examination and observation for other reasons

3.7

11.5

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.5

11.5

302

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

9.3

11.5

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5.7

11.5

Z51.4

ICD-10 Finland

Preparatory care for subsequent treatment, not elsewhere classified

+∞

11.5

ULC02

NOMESCO Finland

Hysteroscopy

2.1

11.5

109

536

EB1BA

NOMESCO Finland

Extensive intraoral X-ray examination

13.7

11.5

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

2.3

11.5

384

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

4.7

11.4

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.3

11.4

378

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

11.4

1128

9860

N03AE01

ATC

clonazepam; systemic

2.3

11.4

411

WX002

NOMESCO Finland

Sedation and analgesia

1.6

11.4

272

1781

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.5

11.3

292

NFR20

NOMESCO Finland

Incomplete excision of soft tissue tumour of hip or thigh

11.9

11.3

QCE20

NOMESCO Finland

Excision and repair of scar or web of skin of upper limb

35.3

11.3

QAJ30

NOMESCO Finland

Other facelift

35.3

11.3

N02BF02

ATC

pregabalin; oral

2.0

11.2

119

609

SPAT1312

SPAT

General health counselling

1.5

11.2

471

3497

S29

ICPC

Skin symptom/complaint other

1.6

11.2

325

2229

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.1

11.2

114

576

R01AD08

ATC

fluticasone; nasal

1.5

11.1

462

3421

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

11.1

198

1199

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

4.0

11.0

I50.9

ICD-10 Finland

Heart failure, unspecified

1.9

11.0

139

756

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

9.3

11.0

B01AB04

ATC

dalteparin; parenteral

2.4

11.0

340

XX1AD

NOMESCO Finland

Other CT-examination

43.6

10.9

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.9

10.9

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

2.2

10.9

459

R78

ICPC

Acute bronchitis/bronchiolitis

3.3

10.8

123

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.1

10.8

480

M79.1

ICD-10 Finland

Myalgia

1.6

10.8

259

1696

CKW99

NOMESCO Finland

Other operation on choroid, vitreous body and retina

10.6

10.8

J01CA04

ATC

amoxicillin; systemic

1.5

10.8

1288

11616

N05AH04

ATC

quetiapine; oral

1.6

10.8

257

1681

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

9.7

10.8

DFF00

NOMESCO Finland

Pure tone audiometry

1.9

10.8

133

719

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

5.0

10.7

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

17.9

10.7

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

5.6

10.7

H02AB06

ATC

prednisolone; systemic

1.4

10.7

706

5699

9722

FHL

Reduction plastic and possible mamilla transposition

21.6

10.7

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

4.2

10.6

Z04.5

ICD-10 Finland

Examination and observation following other inflicted injury

60.4

10.6

PD2BD

NOMESCO Finland

Extensive CT angiography of pelvic organs

60.4

10.6

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

2.1

10.6

107

538

N06AB10

ATC

escitalopram; oral

1.6

10.6

323

2237

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

10.6

325

2254

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

5.3

10.6

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

5.3

10.6

W19

ICD-10 Finland

Unspecified fall

1.9

10.6

134

730

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.5

10.5

278

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

14.3

10.5

NF1DA

NOMESCO Finland

X-ray of hips

3.3

10.4

121

QCG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of upper limb

+∞

10.4

M01AX17

ATC

nimesulide; oral

1.5

10.4

363

2588

HA1SA

NOMESCO Finland

Expansion mammography

7.8

10.4

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

10.3

165

967

V03AE01

ATC

polystyrene sulfonate; oral

8.2

10.3

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

5.2

10.3

R4120

NOMESCO Finland

Occupational therapy

2.1

10.3

482

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.7

10.3

188

1145

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

10.7

10.3

NGQ20

NOMESCO Finland

Amputation of lower leg

10.7

10.3

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

4.6

10.3

J01MA14

ATC

moxifloxacin; systemic

1.9

10.2

132

724

L02AE02

ATC

leuprorelin; implant, parenteral

2.7

10.2

216

ZXE00

NOMESCO Finland

One hour or less

0.7

10.2

328

4512

L14

ICPC

Leg/thigh symptom/complaint

1.9

10.2

133

732

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.5

10.2

264

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

3.2

10.2

123

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

10.2

507

3879

GA5AA

NOMESCO Finland

Rib X-ray examination

13.2

10.2

ZYC01, ,

SPAT

0.3

10.1

1041

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.8

10.1

177

N06AB05

ATC

paroxetine; oral

2.1

10.1

100

500

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

2.8

10.1

172

HA1S1

NOMESCO Finland

Photography of breasts

11.4

10.1

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

2.4

10.0

278

M01AH05

ATC

etoricoxib; oral

1.4

10.0

1010

8738

NF3AA

NOMESCO Finland

Femur X-ray examination

3.4

10.0

109

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

4.1

10.0

M54.5

ICD-10 Finland

Low back pain

1.4

9.9

575

4519

WW500

NOMESCO Finland

Blood transfusion

2.7

9.9

191

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

3.1

9.8

136

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

8.2

9.8

1501

Kela drug reimbursment

Palbociclib

8.2

9.8

C43.73

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip nodular

26.2

9.8

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

3.0

9.8

147

WX202

NOMESCO Finland

Supraclavicular plexus blockade

4.0

9.8

NG1AD

NOMESCO Finland

Knee CT examination

3.5

9.8

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.5

9.8

245

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.3

9.7

346

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.9

9.7

134

751

Z51.6

ICD-10 Finland

Desensitization to allergens

55.3

9.7

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

4.2

9.6

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.5

9.6

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

7.9

9.6

R06.0

ICD-10 Finland

Dyspnoea

1.5

9.5

391

2875

JF2AD

NOMESCO Finland

Colon CT

7.2

9.5

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

7.2

9.5

QDG10

NOMESCO Finland

Excision and repair of bedsore of lower limb

100.6

9.4

C50.01

ICD-10 Finland

Malignant tumor of nipple and areola, ductal tumor

30.2

9.4

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.1

9.4

438

N03AX12

ATC

[U] gabapentin; oral

1.6

9.4

230

1512

ZXM40

NOMESCO Finland

Use of fluorescent substance

21.8

9.4

J05AB11

ATC

valaciclovir; oral

1.6

9.3

241

1605

A06AD11

ATC

lactulose; oral

1.7

9.3

179

1106

M79.6

ICD-10 Finland

Pain in limb

1.4

9.3

705

5785

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

3.0

9.3

141

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

3.5

9.2

B01AF01

ATC

rivaroxaban; oral

1.7

9.2

177

1093

L03.9

ICD-10 Finland

Cellulitis, unspecified

3.2

9.2

110

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.5

9.2

228

J20

ICD-10 Finland

Acute bronchitis

1.7

9.2

173

1063

H25.0

ICD-10 Finland

Senile incipient cataract

1.9

9.1

108

575

QDA10

NOMESCO Finland

Incision of skin of lower limb

7.8

9.1

A06AC51

ATC

ispaghula, combinations; oral

2.2

9.1

382

JF2BD

NOMESCO Finland

Extensive colon CT

4.6

9.1

FN1AD

NOMESCO Finland

CT of coronary arteries

3.0

9.0

127

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

10.1

9.0

C43.79

ICD-10 Finland

Malignant melanoma of the lower extremity including hip or other unspecified histology

10.1

9.0

P01AB01

ATC

metronidazole; oral, rectal

1.4

9.0

649

5273

D17.2

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

2.8

9.0

166

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

3.9

9.0

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.1

9.0

117

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.4

8.9

262

R06AE07

ATC

cetirizine; oral

1.4

8.9

697

5734

XQ800

NOMESCO Finland

Prick test

1.8

8.9

125

704

QWH99

NOMESCO Finland

Other reoperation in surgery of skin

24.1

8.9

394

Kela drug reimbursment

Palbociclib

8.0

8.9

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.8

8.8

156

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.6

8.8

191

1216

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.4

8.8

251

K13.78

ICD-10 Finland

Other change in the oral mucosa

2.6

8.7

192

C43.49

ICD-10 Finland

Malignant melanoma of the scalp and neck other or unspecified histology

50.3

8.7

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.0

8.7

486

A06AH03

ATC

naloxegol; oral

7.7

8.6

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

7.7

8.6

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

8.3

8.6

PD5AD

NOMESCO Finland

CT of aorta

2.9

8.6

142

N05BA01

ATC

diazepam; systemic, rectal

1.6

8.6

187

1194

TNX34

NOMESCO Finland

Major custom molded cast, unspecified region

3.5

8.5

AA1XD

NOMESCO Finland

Other special CT of head and brain

10.1

8.5

L29

ICPC

Musculoskeletal sympt/complt other

1.8

8.5

141

835

SPAT1053

SPAT

Memory test

1.7

8.5

162

998

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

27.7

8.5

SPAT1104

SPAT

Monitoring of emergency patient

2.0

8.5

483

QAE30

NOMESCO Finland

Excision and repair of surgical scar in head or neck

20.1

8.5

R06AX22

ATC

ebastine; oral

1.5

8.5

281

1976

8500/3-C50.8

ICD-O-3

Infiltrating duct carcinoma, NOS, of overlapping lesion of breast

7.4

8.4

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.5

8.4

207

S11

ICPC

Skin infection post-traumatic

3.9

8.4

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

3.1

8.4

111

Z42

ICD-10 Finland

Follow-up care involving plastic surgery

90.5

8.4

NJ3DG

NOMESCO Finland

Very extensive MRI examination of extremities with high intensity magnet

90.5

8.4

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.6

8.4

195

1264

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.0

8.4

436

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

3.5

8.4

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

8.4

114

637

WX1DG

NOMESCO Finland

Very extensive total body MRI with high intensity magnet

+∞

8.3

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.6

8.3

173

K59.0

ICD-10 Finland

Constipation

2.1

8.3

410

D05.0

ICD-10 Finland

Lobular carcinoma in situ

10.8

8.3

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.8

8.3

128

743

R5110, ,

SPAT

1.8

8.3

123

706

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

7.1

8.3

S82

ICPC

Naevus/mole

1.6

8.2

233

1582

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.6

8.2

180

B03XA02

ATC

darbepoetin alfa; parenteral

4.2

8.2

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.2

8.2

292

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

8.2

206

1362

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.8

8.2

146

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

3.1

8.1

103

A02BC04

ATC

rabeprazole; oral

1.7

8.1

152

932

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

2.3

8.1

255

L91.8

ICD-10 Finland

Other hypertrophic disorders of skin

17.3

8.1

R13

ICD-10 Finland

Dysphagia

1.9

8.1

101

549

H25.1

ICD-10 Finland

Senile nuclear cataract

0.6

8.1

166

2536

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.4

8.0

463

3607

D07AC13

ATC

mometasone; topical

1.4

8.0

433

3336

K03.00

ICD-10 Finland

Approximal wear

1.8

8.0

122

705

NHS99

NOMESCO Finland

Other operation for infection of tendon, joint or bone of ankle or foot

22.1

8.0

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

6.3

8.0

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

2.3

8.0

256

H03AA01

ATC

levothyroxine sodium; systemic

1.4

8.0

390

2951

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

3.0

7.9

115

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

2.0

7.9

410

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.5

7.9

195

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.8

7.9

137

L16

ICPC

Ankle symptom/complaint

1.6

7.9

185

1200

D06BB10

ATC

imiquimod; topical

2.0

7.9

411

C43

ICD-10 Finland

Malignant melanoma of skin

13.1

7.9

QBA00

NOMESCO Finland

Puncture of skin of trunk

7.8

7.9

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

7.8

7.9

R22.4

ICD-10 Finland

Localized swelling, mass and lump, lower limb

2.4

7.9

208

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.8

7.9

123

717

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.9

7.8

127

SPAT1255

SPAT

Intravenous administration of medicine

2.0

7.8

462

QB9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in torso, unspecified

7.0

7.8

N28

ICPC

Limited function/disability (N)

3.7

7.7

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

3.7

7.7

ZZQ30

NOMESCO Finland

Free microvascular graft of muscle

45.2

7.7

L01EF03

ATC

abemaciclib; oral

15.1

7.7

ZZQ70

NOMESCO Finland

Free microvascular graft of lymph nodes

15.1

7.7

C50.5

ICD-10 Finland

Malignant neoplasm: Lower-outer quadrant of breast

15.1

7.7

L01CA04

ATC

vinorelbine; systemic

6.4

7.7

DFF15

NOMESCO Finland

Speech audiometry

2.5

7.7

198

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.8

7.7

116

669

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

2.1

7.7

320

TAB20

NOMESCO Finland

Epidural puncture

4.5

7.7

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

4.5

7.7

WF004

NOMESCO Finland

Palliative radiotherapy

3.7

7.6

S79

ICPC

Neoplasm skin benign/unspecified

2.9

7.6

118

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

3.1

7.6

102

A07AA02

ATC

nystatin; oral

2.0

7.6

438

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

6.7

7.6

Z94.0

ICD-10 Finland

Kidney transplant status

11.9

7.6

I79.2*E11.5

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

25.1

7.6

ZZC00

NOMESCO Finland

Graft of fascia

25.1

7.6

R4110, ,

SPAT

1.6

7.6

209

1410

M02AA10

ATC

ketoprofen; topical

1.5

7.5

238

1653

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

8.9

7.5

QAJ10

NOMESCO Finland

Browlift

10.1

7.5

R51

ICD-10 Finland

Headache

1.9

7.5

511

N05BA12

ATC

alprazolam; oral

1.7

7.5

153

959

F45.8

ICD-10 Finland

Other somatoform disorders

1.8

7.5

116

674

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

7.1

7.5

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

3.7

7.5

N29

ICPC

Neurological sympt/complt other

2.9

7.5

114

N06AB06

ATC

sertraline; oral

1.6

7.4

174

1130

UJC12

NOMESCO Finland

Flexible oesophagoscopy

6.5

7.4

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

3.3

7.4

QDG00

NOMESCO Finland

Debridement of bedsore of lower limb

13.4

7.4

QXB10

NOMESCO Finland

Exchange of dressing for large skin wound, unspecified location

13.4

7.4

Q85.00

ICD-10 Finland

Neurofibromatosis, type 1

13.4

7.4

-57

ICPC

Physical medicine/rehabilitation

8.4

7.3

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.2

7.3

260

S01BA01

ATC

dexamethasone; ophthalmic

2.2

7.3

260

A07AA09

ATC

vancomycin; oral

3.6

7.3

WZC00, ,

SPAT

0.5

7.3

1513

G47.3

ICD-10 Finland

Sleep apnoea

1.4

7.3

308

2266

L57.4

ICD-10 Finland

Cutis laxa senilis

10.9

7.3

WC205

NOMESCO Finland

Simple therapy of local tumor recidive with hormone

+∞

7.3

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

+∞

7.3

Z49.2

ICD-10 Finland

Other dialysis

+∞

7.3

QCE35

NOMESCO Finland

Repair of skin defect in upper limb after surgery or injury

+∞

7.3

C49.99

ICD-10 Finland

Malignant tumor in unspecified localization in connective tissue and soft tissue other or unspecified tumor

+∞

7.3

M79.7

ICD-10 Finland

Fibromyalgia

2.2

7.2

294

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

7.2

406

3141

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

7.2

119

704

NFR30

NOMESCO Finland

Extended excision of soft tissue tumour of hip or thigh

15.8

7.2

SPAT1260

SPAT

Consultation of another employee

1.5

7.2

239

1677

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

2.1

7.2

308

NH1CF

NOMESCO Finland

Ankle and foot extensive MRI examination with median intensity magnet

30.1

7.1

QDG99

NOMESCO Finland

Other operation for chronic ulcer or fistula of skin of lower limb

30.1

7.1

QBG30

NOMESCO Finland

Delayed skin closure of surgical wound in trunk

20.1

7.1

CBF10

NOMESCO Finland

Shortening of canthal ligaments and tarsal plate for ectropion

20.1

7.1

-56

ICPC

Dressing/pressure/compress/tamponade

3.2

7.1

TNG10

NOMESCO Finland

Puncture of knee

3.5

7.1

H26.3

ICD-10 Finland

Drug-induced cataract

6.6

7.1

17402

ICD-8 Finland

Malignant neoplasm of breast, Glandulae

12.1

7.1

HA1DA

NOMESCO Finland

Restricted mammography

12.1

7.1

L17

ICPC

Foot/toe symptom/complaint

1.4

7.1

453

3579

Y84.9

ICD-10 Finland

Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

6.1

7.1

L01XE33

ATC

[U] palbociclib

10.1

7.0

OAB42, ,

SPAT

0.5

7.0

1446

M03AX01

ATC

botulinum toxin; parenteral

3.1

7.0

J01CF02

ATC

cloxacillin; systemic

2.8

7.0

118

NHK40

NOMESCO Finland

Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone

2.7

7.0

135

NE1BA

NOMESCO Finland

Pelvis extensive X-ray examination

3.2

7.0

QBE00

NOMESCO Finland

Excision of loose skin or fold of skin from trunk

7.0

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

7.0

A11CC03

ATC

alfacalcidol; systemic

3.2

7.0

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.0

7.0

102

Y83.1

ICD-10 Finland

Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.3

7.0

N06AA10

ATC

nortriptyline; systemic

2.6

7.0

153

SPAT1301

SPAT

No procedures

1.4

6.9

410

3196

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

2.4

6.9

202

Y96.9

ICD-10 Finland

Unspecified type of accident

3.1

6.9

JDB10

NOMESCO Finland

Percutaneous gastrostomy

7.6

6.9

J01XX08

ATC

linezolid; systemic

7.6

6.9

EB1AD

NOMESCO Finland

Cone beam CT of teeth and jaws (one quarter)

7.6

6.9

-42

ICPC

Electrical tracing

3.6

6.9

D06BX02

ATC

ingenol mebutate; topical

3.6

6.9

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

2.9

6.9

103

N61

ICD-10 Finland

Inflammatory disorders of breast

2.4

6.9

203

J02AC02

ATC

itraconazole; systemic

1.5

6.9

274

1994

PA7BD

NOMESCO Finland

CT angiography of neck and brain

3.2

6.9

A41.8

ICD-10 Finland

Other specified sepsis

3.3

6.8

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.1

6.8

301

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

3.0

6.8

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

6.7

6.8

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.4

6.8

185

Z31.6

ICD-10 Finland

General counselling and advice on procreation

6.1

6.8

NE1DG

NOMESCO Finland

Pelvic, hip and femur very extensive MRI examination with high intensity magnet

6.1

6.8

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

6.8

315

2357

Z80.9

ICD-10 Finland

Family history of malignant neoplasm, unspecified

16.8

6.7

V500A

ICD-9 Finland

Elective surgery for purposes other than remedying health states, Hair transplant

16.8

6.7

M25.5

ICD-10 Finland

Pain in joint

1.3

6.7

536

4373

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

3.2

6.7

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.5

6.7

174

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

6.7

152

979

C50.52

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor

7.2

6.7

L08

ICPC

Shoulder symptom/complaint

1.4

6.7

349

2663

F34.1

ICD-10 Finland

Dysthymia

2.2

6.7

257

QBJ05

NOMESCO Finland

Other correction of loose or redundant skin of trunk

22.6

6.7

N06AX21

ATC

duloxetine; oral

1.6

6.7

180

1208

M15

ICD-10 Finland

Polyarthrosis

1.8

6.6

510

NA2AD

NOMESCO Finland

Thoracic spine CT examination

5.9

6.6

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

5.9

6.6

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

3.4

6.6

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

3.4

6.6

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

8.7

6.6

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

8.7

6.6

QWC00

NOMESCO Finland

Reoperation for superficial infection in surgery of skin

8.7

6.6

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

8.7

6.6

NB6AA

NOMESCO Finland

Humerus X-ray examination

2.6

6.5

146

L08

ICD-10 Finland

Other local infections of skin and subcutaneous tissue

2.7

6.5

123

J01DA09

ATC

[U] cefadroxil

1.4

6.5

385

3001

R55

ICD-10 Finland

Syncope and collapse

1.6

6.4

134

845

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

6.4

493

A03CA05

ATC

glycopyrronium bromide and psycholeptics; systemic

3.5

6.4

TKC20

NOMESCO Finland

Catheterisation of bladder

1.9

6.4

399

R42

ICD-10 Finland

Dizziness and giddiness

1.4

6.4

320

2421

ZX090

NOMESCO Finland

Other technic of radiotherapy

2.4

6.4

184

C07AA05

ATC

propranolol; systemic

1.4

6.4

310

2333

NG1DG

NOMESCO Finland

Knee and lower leg very extensive MRI examination with high intensity magnet

7.4

6.4

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

6.4

384

2996

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.6

6.4

136

L81

ICPC

Injury musculoskeletal NOS

2.4

6.4

166

M01AB51

ATC

indometacin, combinations; oral, rectal

2.5

6.4

148

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

2.5

6.4

148

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.2

6.4

249

D07BC01

ATC

betamethasone and antiseptics; topical

1.6

6.4

164

1089

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

6.4

1006

9001

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

4.1

6.4

G44.2

ICD-10 Finland

Tension-type headache

1.5

6.3

219

1548

T88.8

ICD-10 Finland

Other specified complications of surgical and medical care, not elsewhere classified

6.6

6.3

ZXF00

NOMESCO Finland

Interruption caused by intraoperative deterioration of general condition

8.2

6.3

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

8.2

6.3

NC1BA

NOMESCO Finland

Elbow extensive X-ray examination

5.2

6.3

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.4

6.3

357

2758

EP1BG

NOMESCO Finland

MRI examination of soft tissue of neck with high intesity magnet

6.0

6.3

QDG30

NOMESCO Finland

Delayed skin closure of surgical wound in lower limb

11.1

6.3

QCD20

NOMESCO Finland

Excision of burn of upper limb and coverage

11.1

6.3

1515, ,

Kela drug reimbursment

9.3

6.3

3030

Kela drug reimbursment

Abemaciclib

9.3

6.3

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.3

6.3

205

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

3.9

6.3

NH1DF

NOMESCO Finland

Ankle and foot very extensive MRI examination with median intensity magnet

+∞

6.3

Z51.2

ICD-10 Finland

Other chemotherapy

+∞

6.3

HAC99

NOMESCO Finland

Other mastectomy

+∞

6.3

Z3226

NOMESCO Finland

Physiotherapist

1.5

6.2

225

1604

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

6.2

140

900

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

6.2

389

3053

C03DA01

ATC

spironolactone; oral

1.6

6.2

144

933

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.9

6.2

397

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

2.7

6.2

115

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

6.2

270

1996

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

4.0

6.2

C43.70

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip without histology

6.3

6.2

J01MA06

ATC

norfloxacin; oral

1.5

6.2

201

1405

TAC99

NOMESCO Finland

Other blockade for chronic pain

5.4

6.2

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

6.1

118

730

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

6.1

213

1508

WX780

NOMESCO Finland

Remote monitoring CPAP

0.2

6.1

330

N64.4

ICD-10 Finland

Mastodynia

2.0

6.1

294

I50

ICD-10 Finland

Heart failure

2.7

6.1

116

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

4.1

6.1

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

12.6

6.1

GA1CG

NOMESCO Finland

Extensive MRI of chest

12.6

6.1

N18.0

ICD-10 Finland

End-stage renal disease

12.6

6.1

M86.6

ICD-10 Finland

Other chronic osteomyelitis

12.6

6.1

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

12.6

6.1

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

2.2

6.1

234

J05AB01

ATC

aciclovir; systemic

1.4

6.1

342

2639

K07.60

ICD-10 Finland

Snapping jaw

1.8

6.1

495

KH1AD

NOMESCO Finland

CT of urinary organs

2.2

6.0

228

K03.0

ICD-10 Finland

Excessive attrition of teeth

2.2

6.0

215

E66.8

ICD-10 Finland

Other obesity

1.8

6.0

526

WX704

NOMESCO Finland

Intubation

0.4

6.0

679

ZXH06, ,

SPAT

0.3

6.0

472

A12AA04

ATC

calcium carbonate; oral

5.2

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019225) pH of Specimen

634

1333

7.20

312.36

5.0

3.4

7.37

7.35

2.04

448

918

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

732

1807

6.60

304.54

5.2

4.9

32.73

32.93

0.16

447

1211

(3022313) Gas panel - Capillary blood

287

492

6.88

165.66

4.1

2.8

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

826

3384

3.96

162.07

2.8

2.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

248

402

7.11

150.48

4.4

2.7

24.79

25.02

mmol/l

0.52

220

364

(3044640) Blood type and Crossmatch panel - Blood

925

4485

3.50

132.44

3.1

2.1

—

(3009343) pH of Capillary blood

299

684

5.14

125.26

4.3

2.7

7.41

7.42

1.38

232

561

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

299

704

4.99

120.83

4.3

2.7

5.17

5.15

kpa

0.15

276

679

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

254

594

4.89

102.71

4.4

2.6

1.27

1.80

mmol/l

1.30

199

444

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

451

1696

3.31

92.20

6.1

5.9

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

205

441

5.18

91.11

2.0

1.7

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

191

398

5.31

87.95

1.9

1.6

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1009

6196

2.69

78.23

6.8

5.0

1.22

mmol/l

1.94

865

5695

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1027

6523

2.59

71.57

3.2

2.5

—

estimate

—

(40768804) Tissue Pathology biopsy report

987

6170

2.55

70.88

2.9

2.1

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1052

6878

2.53

66.95

8.3

5.4

1.22

mmol/l

0.46

896

5902

(4035726) Immunohistochemistry procedure

321

1190

3.12

65.10

1.5

1.4

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1076

7212

2.49

63.16

9.7

5.3

10.23

10.65

umol/l

0.32

1013

6852

(3008757) Leukocyte morphology finding [Identifier] in Blood

103

8.44

62.74

2.4

3.8

—

(40768793) Breast Pathology biopsy report

173

485

3.88

53.95

1.5

1.4

—

(3042936) Bacteria identified in Isolate by Culture

383

1757

2.55

50.62

2.7

1.8

—

(3045424) Erythrocytes [Presence] in Urine

194

654

3.24

45.35

2.2

2.0

0.00

0.01

estimate

0.80

195

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1364

10883

2.66

44.83

12.5

6.9

80.72

75.74

u/l

2.85

1275

10286

(3017354) Segmented neutrophils/Leukocytes in Blood

111

6.55

42.51

3.6

3.5

58.45

52.19

1.17

101

(3023368) Bacteria identified in Blood by Culture

555

3179

2.14

42.48

3.7

3.6

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

148

5.64

41.56

1.6

1.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

776

5066

2.03

41.34

4.3

3.2

35.58

45.21

ng/l

0.31

557

3247

(3025468) Yersinia sp identified in Specimen by Organism specific culture

146

5.64

41.08

1.6

1.4

—

(4146454) Self-monitoring of blood glucose

150

5.56

40.96

2.6

2.7

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

147

5.60

40.78

1.6

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

156

5.34

39.24

1.7

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

153

5.38

39.04

1.7

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

157

5.31

38.96

1.7

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

192

4.85

38.88

1.3

—

(3032080) INR in Blood by Coagulation assay

837

5704

1.97

38.49

13.4

11.7

1.19

inr

0.14

646

4634

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

275

1215

2.52

38.44

2.5

2.1

0.20

0.22

g/l

2.46

259

1152

(3019309) Folate [Moles/volume] in Red Blood Cells

402

2098

2.22

38.37

1.8

1.7

959.22

1204.27

nmol/l

6.74

251

1589

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

279

1267

2.45

36.65

3.9

3.8

22.33

15.98

ug/l

0.18

206

994

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

598

3692

1.99

36.01

3.3

2.6

1471.77

826.33

ng/l

2.16

450

3104

(3002256) Pathology report gross observation

383

2011

2.19

35.70

1.7

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

157

4.96

33.93

1.9

2.1

29.78

24.04

mg/l

0.30

(3013826) Glucose [Moles/volume] in Serum or Plasma

1045

7893

1.92

33.14

4.7

4.1

6.56

6.55

mmol/l

0.01

985

7431

(3007853) Bacteria identified in Skin by Aerobe culture

299

1461

2.29

32.98

2.2

1.6

—

(3021589) Normoblasts [#/volume] in Blood

382

6287

0.49

32.84

9.8

9.5

0.00

e9/l

0.09

297

5119

(1617658) Protocol used for examination of sentinel lymph nodes

154

4.92

32.72

1.1

—

(3019069) Monocytes/Leukocytes in Blood

898

6485

1.87

32.45

6.7

6.1

8.73

8.60

0.66

796

6061

(3017732) Neutrophils [#/volume] in Blood

349

1830

2.16

32.29

3.0

3.95

4.23

e9/l

0.73

209

1595

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

103

287

3.77

32.14

1.2

1.3

33.14

30.24

u/l

0.31

233

(3013650) Neutrophils [#/volume] in Blood by Automated count

1057

8068

1.90

31.79

11.1

8.2

3.73

3.92

e9/l

2.42

946

6968

(3014271) Vancomycin [Susceptibility]

9.06

31.65

3.0

2.5

—

(3018010) Neutrophils/Leukocytes in Blood

899

6534

1.85

31.42

6.2

5.9

57.31

56.39

1.55

802

6225

(3037121) Protein [Mass/volume] in Urine

125

402

3.29

31.32

3.5

2.6

367.98

285.99

mg/l

0.53

146

(3006504) Eosinophils/Leukocytes in Blood

891

6467

1.85

31.18

6.4

6.0

2.85

0.01

784

6033

(3022096) Basophils/Leukocytes in Blood

889

6475

1.83

30.48

6.7

6.1

0.72

0.70

0.48

783

6030

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

126

414

3.22

30.47

2.1

184.49

320.98

ug/l

0.61

113

385

(3004809) Band form neutrophils/Leukocytes in Blood

169

4.54

30.14

3.4

3.7

1.91

1.17

0.62

156

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

930

6920

1.81

29.18

2.8

2.4

79.40

78.92

nmol/l

0.20

761

6288

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

116

380

3.21

28.17

1.4

1.2

—

(3002030) Lymphocytes/Leukocytes in Blood

895

6654

1.78

27.46

6.3

6.0

27.97

28.94

2.01

819

6286

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

641

4350

1.79

26.71

2.9

2.3

66.21

78.54

u/l

0.25

572

3985

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

164

669

2.62

26.64

1.7

1.5

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

5.79

26.09

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

117

4.83

24.42

1.3

1.8

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

337

1918

1.96

24.21

2.1

1.7

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

5.29

23.71

2.9

2.3

—

(3013115) Eosinophils [#/volume] in Blood

956

7420

1.71

23.53

6.4

6.1

0.19

e9/l

0.01

828

6463

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1177

9695

1.80

23.28

4.8

3.1

54.61

40.97

u/l

3.48

1077

9108

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

133

4.41

22.61

1.2

—

32.40

—

(1761868) Lipid panel - Serum or Plasma

392

5928

0.55

22.53

2.5

3.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

126

4.48

22.33

1.3

1.7

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

202

980

2.21

22.16

2.6

51.50

50.67

u/ml

0.01

197

948

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

826

6244

1.66

21.76

2.4

2.0

109.42

99.30

pmol/l

5.31

429

3097

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

7.08

21.25

2.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

7.16

20.81

1.6

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

7.16

20.81

1.6

1.2

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

160

3.92

20.74

1.2

—

75.67

—

(3006315) Basophils [#/volume] in Blood

914

7178

1.63

20.00

6.3

5.9

0.04

e9/l

0.31

800

6151

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

5.05

19.77

1.1

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

229

3.34

19.70

1.5

1.6

—

(3001604) Monocytes [#/volume] in Blood

909

7152

1.62

19.54

6.3

5.9

0.55

e9/l

0.10

797

6137

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

1505

13706

2.52

19.26

17.1

12.1

82.28

82.46

ml/min/173m2

0.13

1391

12654

(3019198) Lymphocytes [#/volume] in Blood

925

7330

1.62

19.13

6.4

5.9

1.81

1.97

e9/l

2.91

815

6439

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

241

1324

1.96

18.83

4.2

4.3

231.32

231.71

u/l

0.02

208

1254

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

517

3564

1.66

18.77

2.5

2.2

3.21

2.75

mg/l

3.60

406

3050

(3045414) Leukocytes [Presence] in Urine

244

1353

1.95

18.54

2.2

2.0

0.00

0.03

estimate

1.05

262

(3037467) Urinalysis macro (dipstick) panel - Urine

1148

9639

1.67

18.42

5.4

4.2

—

3.26

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

274

1593

1.87

17.99

5.8

3.6

1.07

1.01

mmol/l

2.31

241

1438

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

6.77

17.88

1.3

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

6.77

17.88

1.3

1.9

—

(36660697) Celiac disease serology panel - Serum

233

1287

1.95

17.87

1.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

552

3909

1.63

17.82

1.8

1.6

21.65

21.43

nmol/l

0.11

362

3261

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

379

2.69

17.64

2.1

1.7

0.82

2.23

ug/l

1.80

339

(3012095) Magnesium [Moles/volume] in Serum or Plasma

327

2018

1.78

17.63

3.0

2.6

0.83

0.82

mmol/l

0.11

287

1897

(40768443) Skin Pathology biopsy report

142

664

2.25

16.93

1.3

1.2

—

(3023520) Reticulocytes [#/volume] in Blood

195

1034

2.01

16.77

2.7

2.6

69.34

70.38

e9/l

0.16

165

745

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

6.52

16.67

1.3

1.9

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

206

1117

1.97

16.62

1.4

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

151

730

2.18

16.59

1.5

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

579

4212

1.59

16.40

2.3

2.1

140.26

196.27

u/l

1.35

542

3971

(3032057) Clostridioides difficile [Presence] in Stool

14.43

16.33

1.3

2.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

209

3.20

16.29

2.8

3.2

194.35

53.80

u/ml

0.62

196

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

382

2.58

15.82

1.6

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

5.34

15.63

1.6

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

357

2.61

15.41

2.5

2.7

—

(40761536) Microorganisms panel - Urine sediment

1167

0.25

15.11

3.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

5.16

15.08

1.6

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

5.26

14.40

1.2

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

5.26

14.40

1.2

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

5.26

14.40

1.2

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

5.26

14.40

1.2

1.8

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1235

10831

1.60

13.95

5.7

4.3

13.58

11.26

mm/h

5.33

1096

10155

(3000570) Elastase.pancreatic [Mass/mass] in Stool

395

2.44

13.82

1.4

291.76

305.01

ug/g

0.21

211

(3004789) Transferrin [Mass/volume] in Serum or Plasma

303

1950

1.68

13.74

2.4

2.0

2.37

2.38

g/l

0.10

255

1794

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

158

837

1.98

13.56

1.7

1.5

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

759

6034

1.49

13.46

4.6

3.9

35.27

36.52

g/l

6.56

683

5663

(3018418) pH of Serum or Plasma

279

4161

0.60

13.15

5.8

3.3

7.39

7.40

0.53

208

2867

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

278

1775

1.68

12.93

2.5

2.0

22.48

23.48

0.46

241

1637

(3019550) Sodium [Moles/volume] in Serum or Plasma

1526

14305

2.29

12.69

22.1

14.2

139.89

139.84

mmol/l

0.37

1479

14034

(40768797) Stomach Pathology biopsy report

317

2113

1.62

12.42

1.3

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

187

1078

1.83

12.40

3.8

2.7

68.87

73.18

ng/l

0.38

150

936

(3023103) Potassium [Moles/volume] in Serum or Plasma

1527

14340

2.27

12.26

22.3

14.3

3.97

3.95

mmol/l

2.18

1470

14038

(3027945) Reticulocytes/Erythrocytes in Blood

222

1351

1.75

12.26

2.7

2.5

1.94

1.77

1.31

165

1203

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1498

13975

2.04

12.11

20.6

12.3

20.69

21.64

mg/l

0.63

1300

11202

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

104

3.62

11.48

1.3

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

104

3.62

11.48

1.3

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

104

3.62

11.48

1.3

1.6

—

(3022948) Iron [Moles/volume] in Serum or Plasma

315

2140

1.59

11.31

2.5

2.0

12.65

13.86

umol/l

1.89

278

1981

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

407

2.26

11.21

1.1

11.83

5.94

eliau/ml

—

(3002582) Erythrocytes [#/volume] in Urine

295

4213

0.63

11.16

3.1

2.9

56.19

80.35

e6/l

0.32

213

3112

(3022145) Colonoscopy Study observation

263

1719

1.63

11.06

1.3

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

644

5094

1.44

11.00

4.6

2.9

2.37

2.36

mmol/l

1.18

522

4642

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

4.76

10.72

1.8

1.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

446

5806

0.68

10.58

3.4

3.6

0.09

0.16

estimate

0.26

1199

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

4.85

10.50

1.0

1.6

42.85

40.53

g/l

1.31

(3030467) Casts [#/volume] in Urine by Automated count

252

3657

0.63

10.05

2.7

2.8

0.43

0.37

e6/l

0.16

171

2576

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

108

560

2.00

9.86

1.3

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

464

2.09

9.81

1.5

1.7

1.70

1.50

g/l

1.07

408

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

345

2.26

9.77

1.3

—

10.66

—

(40761511) CBC panel - Blood by Automated count

1530

14516

2.10

9.69

19.5

11.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

3.38

9.33

1.2

1.3

—

(3044927) Protein electrophoresis panel - Urine

125

3.09

9.27

1.3

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

170

2.76

9.14

1.1

1.6

292.34

331.03

mu/l

0.83

132

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

148

2391

0.58

9.08

4.0

3.1

106.83

390.89

ng/l

2.91

105

1703

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1447

13543

1.68

8.93

7.0

5.8

1.87

mu/l

0.01

1249

12639

(3023183) Ammonium ion [Moles/volume] in Plasma

221

2.49

8.77

2.3

2.9

29.60

35.40

umol/l

1.06

200

(3001122) Ferritin [Mass/volume] in Serum or Plasma

842

7154

1.37

8.76

3.2

2.9

121.12

96.78

ug/l

2.88

732

6720

(36304419) Bacteria [Presence] in Urine

246

3498

0.65

8.73

2.7

—

0.00

estimate

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

119

3.07

8.73

10.1

5.3

13.19

11.88

mg/l

0.96

111

(3000475) Leukocytes [#/volume] in Synovial fluid

336

2.20

8.69

2.0

1.6

19331.02

8841.87

e6/l

0.85

238

(3041096) Erythrocytes [Presence] in Urine by Automated

299

4075

0.67

8.57

2.4

2.9

0.00

0.30

estimate

0.77

1160

(3026782) Osmolality of Urine

149

2359

0.59

8.40

2.3

2.4

468.49

516.82

mosm/kgh2o

2.27

124

2031

(3000850) Epithelial cells [#/volume] in Urine

194

2880

0.63

8.34

2.8

2.4

7.75

7.08

e6/l

0.15

178

2596

(3005570) Glucose [Moles/volume] in Urine

123

2.97

8.26

2.3

2.0

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1549

14845

2.17

8.22

17.1

10.9

26.36

24.48

u/l

2.85

1464

14454

(3018095) Leukocytes [#/volume] in Urine

387

4995

0.70

8.14

3.5

3.4

61.17

94.59

e6/l

0.83

239

3323

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

484

1.96

8.09

1.3

2.15

9.33

u/ml

1.54

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

442

2.00

8.08

1.7

1.4

69.48

162.85

pmol/l

1.54

433

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

295

2114

1.48

8.07

1.6

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

485

1.95

8.05

1.2

1.3

6.86

7.73

u/ml

—

(3019150) Specific gravity of Urine by Refractometry

243

3408

0.66

7.95

4.5

4.0

1.02

1.48

kg/l

0.50

172

2177

(3020779) Urea [Moles/volume] in Serum or Plasma

151

936

1.68

7.74

7.9

4.4

10.08

8.42

mmol/l

1.72

143

889

(4015189) Microbial culture of sputum

7.46

7.67

1.5

2.3

—

(40761535) Cells panel - Urine sediment

168

1074

1.63

7.64

3.6

3.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

107

3.03

7.64

1.0

1.2

—

(3000494) Fungus identified in Specimen by Culture

255

1794

1.50

7.61

1.5

1.4

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1551

14912

2.11

7.48

26.5

16.4

73.48

71.15

umol/l

2.30

1511

14754

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

278

2.20

7.41

2.1

2.5

0.32

0.39

iu/ml

0.94

143

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

419

3254

1.39

7.31

1.7

1.6

0.90

1.02

mg/l

0.73

306

2495

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

191

2.45

7.30

1.3

1.6

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

105

598

1.81

7.26

2.6

1.9

40.59

40.60

u/l

0.00

545

(3023420) DNA double strand Ab [Units/volume] in Serum

116

681

1.76

7.24

1.5

2.1

12.59

8.79

iu/ml

0.40

174

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

154

977

1.64

7.22

1.4

1.3

73.21

48.05

au/ml

0.60

(3017143) Hepatitis C virus Ab [Presence] in Serum

218

1504

1.52

7.12

1.5

1.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

7.56

6.90

1.0

1.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

244

3333

0.68

6.83

4.1

4.6

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

8.30

6.83

1.1

1.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

400

3119

1.38

6.73

1.6

1.4

2.33

2.31

g/l

0.07

214

1939

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

337

2.03

6.73

1.4

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

465

3719

1.35

6.65

1.4

1.3

2.64

1.56

u/ml

0.42

1026

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

7.84

6.61

1.0

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

272

2.14

6.58

1.6

1.5

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

195

1336

1.52

6.57

2.4

2.1

354.23

373.37

nmol/l

0.68

168

1231

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

3.76

6.37

1.3

2.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

8.18

6.33

1.2

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1315

0.54

6.32

2.3

2.7

—

(3036670) Protein [Mass/volume] in Synovial fluid

5.04

6.18

1.6

1.3

44.88

40.41

g/l

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

7.70

6.12

2.5

2.4

—

(3006462) Nitrate [Presence] in Urine

3.48

6.01

6.2

3.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

7.27

5.92

2.5

2.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

101

2.80

5.90

1.1

1.2

—

(3033099) Centromere Ab [Titer] in Serum

5.04

5.87

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

159

1072

1.54

5.78

2.8

2.4

17.91

20.67

au/ml

0.17

121

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

393

1.87

5.75

2.9

2.0

11.81

11.65

mg/l

0.07

364

(3048689) Calprotectin [Mass/mass] in Stool

270

2020

1.40

5.75

2.3

142.12

108.93

ug/g

1.11

195

1603

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

103

2.75

5.70

1.1

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

113

705

1.65

5.69

2.4

2.3

—

(3028433) Virus identified in Specimen by Culture

4.76

5.61

1.1

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

129

836

1.59

5.57

1.7

1.12

1.41

g/l

2.07

115

768

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

237

2.10

5.51

1.2

1.3

—

(3020491) Glucose [Moles/volume] in Blood

100

2.73

5.44

1.3

1.5

6.16

6.83

mmol/l

0.74

(3026493) Urate [Moles/volume] in Serum or Plasma

437

3561

1.31

5.31

3.1

2.3

329.82

321.31

umol/l

0.90

354

3142

(3005719) IgG [Mass/volume] in Serum or Plasma

152

1037

1.51

5.24

2.6

2.7

10.26

10.76

g/l

0.77

138

945

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

126

2.49

5.22

1.2

1.1

108.23

115.58

pmol/l

0.42

126

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

3.66

5.21

1.0

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

377

1.84

5.20

1.8

1.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

203

2.15

5.16

4.8

4.7

5654.22

542.71

iu/ml

—

(3020630) Protein [Mass/volume] in Serum or Plasma

152

1041

1.51

5.15

3.2

2.6

66.97

67.40

g/l

0.28

129

958

(4034850) Laboratory test

505

0.35

5.14

13.3

9.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

134

2.42

5.07

2.0

1.4

156488.68

127739.04

e6/l

0.08

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

559

6510

0.78

5.04

1.8

1.9

1.36

1.32

mmol/l

0.51

427

5464

(3004588) Protein electrophoresis panel - Serum or Plasma

130

865

1.55

5.03

2.7

2.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

4.72

4.99

1.2

1.0

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

141

2018

0.67

4.92

2.5

2.6

4.68

3.68

e6/l

0.35

887

(3003327) Ova and parasites identified in Stool by Light microscopy

537

1.68

4.86

1.9

1.7

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

7.73

4.85

1.1

1.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1260

11792

1.32

4.84

5.5

4.8

14.89

14.66

pmol/l

2.54

1078

10923

(4211845) Urine protein measurement

3.01

4.83

6.2

3.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

131

2.39

4.83

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

357

1.83

4.82

1.1

1.2

18.17

12.50

u/l

1.72

285

(3006571) Granulocytes/Leukocytes in Synovial fluid

157

2.26

4.77

1.9

1.6

55.75

58.22

0.13

100

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

4.44

4.75

1.1

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

2.66

4.66

1.4

1.6

24.83

16.08

u/ml

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

390

1.75

4.41

1.1

5.04

5.39

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1410

13461

1.38

4.40

5.0

4.2

1.29

1.25

mmol/l

1.63

1190

12459

(4281824) Cell count and differential, peritoneal fluid

176

2.13

4.40

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

6.28

4.29

1.2

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

373

1.75

4.21

1.2

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

4.14

4.21

1.2

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

480

0.41

4.09

1.9

1.8

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.22

4.01

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

290

1.82

3.97

1.4

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

226

1.93

3.94

1.1

1.2

5.75

4.97

u/ml

0.12

(3006270) Folate [Moles/volume] in Blood

112

2.34

3.93

1.1

448.42

386.22

nmol/l

0.96

105

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.81

3.89

1.1

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

798

0.55

3.88

2.0

2.5

99.87

170.20

ng/l

2.03

721

(3010813) Leukocytes [#/volume] in Blood

1563

15281

1.80

3.85

32.8

20.0

6.59

6.55

e9/l

0.31

1531

14944

(1761482) Bacteria [#/volume] in Urine by Culture

259

0.31

3.84

3.1

3.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.70

3.83

1.2

—

(3019174) dRVVT (LA screen)

6.03

3.81

1.0

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

122

852

1.47

3.80

1.1

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

3.96

3.79

1.2

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

164

1211

1.39

3.77

1.2

161.37

148.26

u/ml

0.14

481

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

144

1044

1.42

3.68

4.0

3.4

4.36

4.52

pmol/l

1.25

115

934

(3000034) Microalbumin [Mass/volume] in Urine

0.00

3.63

0.0

2.7

—

12.40

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

367

1.69

3.62

4.0

3.2

34.73

54.49

mg/l

1.03

328

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

174

2276

0.74

3.58

2.5

1.41

1.07

e6/l

0.60

1153

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

369

1.68

3.56

4.0

3.2

33.47

35.60

mg/l

0.14

332

(3007461) Platelets [#/volume] in Blood

1561

15276

1.73

3.54

32.7

19.9

260.58

259.56

e9/l

0.25

1532

14994

(3024731) MCV [Entitic mean volume] in Red Blood Cells

1561

15277

1.73

3.53

32.6

19.9

91.23

91.06

0.86

1534

15138

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

1561

15279

1.73

3.50

32.9

20.2

39.39

40.20

8.83

1534

15136

(3035941) MCH [Entitic mass]

1561

15279

1.73

3.50

32.5

19.8

30.20

30.26

0.65

1534

15140

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

214

0.28

3.48

1.0

1.5

48.13

55.58

ug/l

—

214

(3026361) Erythrocytes [#/volume] in Blood

1561

15280

1.72

3.48

32.7

19.9

4.37

4.47

e12/l

14.16

1529

14947

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

395

1.65

3.47

1.4

1.7

—

(40768441) Liver Pathology biopsy report

100

2.32

3.43

1.0

1.4

—

(3000963) Hemoglobin [Mass/volume] in Blood

1561

15285

1.71

3.41

32.9

20.0

130.97

134.40

g/l

19.77

1534

15148

(3028308) Erythrocytes [#/volume] in Pleural fluid

101

2.30

3.36

1.3

1.4

61741.69

196895.67

e6/l

0.69

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

5.74

3.34

1.4

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

274

2223

1.28

3.32

1.5

1.3

457.22

555.94

titre

0.55

502

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

471

1.58

3.32

1.4

1.3

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.44

3.31

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.66

3.29

1.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

683

7563

0.83

3.28

3.5

3.7

0.00

estimate

0.80

1461

(3027923) C peptide [Moles/volume] in Serum or Plasma

2.45

3.22

1.3

1.5

1.61

1.24

nmol/l

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

273

1.74

3.20

1.4

1.5

—

(3044009) aPTT.lupus sensitive (LA screen)

5.35

3.19

1.0

1.2

—

(4195642) Thrombophilia screening test

207

1.86

3.18

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

4.52

3.11

1.0

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

4.52

3.11

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

4.52

3.11

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

4.52

3.11

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

3.45

3.10

1.2

1.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1422

13718

1.31

3.10

6.2

5.1

5.84

5.83

mmol/l

0.13

1192

12675

(3035350) Ketones [Presence] in Urine by Test strip

694

7644

0.84

3.06

3.5

3.7

23.98

3.92

estimate

0.39

1502

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

347

2925

1.24

3.02

1.4

1.3

14.55

10.86

u/ml

0.30

1179

(3042631) Mycobacterium sp identified in Specimen

147

1.99

3.01

2.3

2.5

—

(3003396) Base excess in Arterial blood by calculation

170

1311

1.33

3.00

5.5

6.9

0.75

0.95

mmol/l

0.26

149

1071

(3014007) Fractional oxyhemoglobin in Arterial blood

113

816

1.41

3.00

6.0

8.7

94.81

93.91

0.54

113

810

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

606

1.48

3.00

1.7

1.6

3.21

4.15

mg/l

0.41

451

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.57

2.99

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

2.25

2.97

1.0

—

(1616796) Gas panel - Central venous blood

208

0.33

2.93

1.4

2.7

—

(3020876) Protein [Mass/time] in 24 hour Urine

135

2.02

2.91

2.7

2.3

1.09

1.08

g/24h

0.01

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

373

3180

1.23

2.91

1.4

1.3

49.80

30.46

iu/ml

0.93

101

985

(40763480) Human metapneumovirus Ag [Presence] in Specimen

6.69

2.87

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

230

1.76

2.85

1.1

7.84

3.16

eliau/ml

0.45

112

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

449

1.54

2.84

1.7

2.2

0.27

0.68

g/l

1.08

388

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

2.20

2.84

7.2

6.4

27.35

207.58

ug/l

0.45

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

223

1.77

2.83

1.0

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

172

1.88

2.82

3.3

3.6

0.77

nmol/l

0.00

143

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.78

2.82

1.1

1.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

144

1.96

2.81

1.1

1.2

—

(3021901) Oxygen saturation in Capillary blood

190

0.31

2.80

4.7

2.3

91.95

89.95

—

185

(4268621) Lupus anticoagulant assay

159

1.90

2.76

2.0

2.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

405

1.55

2.72

1.3

1.2

50.00

105.68

titre

—

(40765096) Chromosome analysis panel by Banding

3.01

2.69

1.3

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

3.46

2.69

1.2

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

136

1034

1.34

2.66

1.3

1.4

—

(3003694) ABO and Rh group [Type] in Blood

347

4029

0.82

2.64

1.4

—

(3009261) Glucose [Presence] in Urine by Test strip

707

7710

0.85

2.60

3.6

3.7

0.00

0.22

estimate

0.53

1424

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

304

0.42

2.60

1.4

1.6

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

100

2.11

2.59

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

3.61

2.57

1.0

1.2

—

(3044941) Cell count panel - Synovial fluid

230

1.71

2.57

1.5

1.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

125

944

1.35

2.57

2.2

2.1

4.44

6.39

ug/l

1.17

841

(3035933) Granulocytes/Leukocytes in Blood

302

0.43

2.56

1.5

3.3

59.92

57.76

0.28

302

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

162

0.31

2.56

1.6

1.2

—

(3022621) pH of Urine by Test strip

149

1156

1.32

2.55

2.5

2.4

6.03

6.09

0.30

740

(3019977) pH of Arterial blood

169

1335

1.30

2.54

5.6

6.9

7.41

7.42

0.32

704

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

108

2.05

2.52

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

136

1.93

2.51

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

970

9079

1.17

2.50

3.1

3.0

—

(3010838) Calcium [Moles/time] in 24 hour Urine

294

1.62

2.50

1.5

2.0

4.58

5.11

mmol/24h

0.54

258

(3033658) Prothrombin time (PT) actual/Normal

398

3463

1.20

2.49

4.3

3.4

97.70

94.30

1.92

389

3384

(3026051) Granulocytes/Leukocytes in Pleural fluid

4.39

2.47

1.4

1.2

13.43

19.70

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

296

1.61

2.44

1.4

0.41

0.37

nmol/l

0.18

230

(3012565) Volume of 24 hour Urine

0.00

2.42

0.0

2.4

—

1954.91

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1386

13405

1.24

2.41

7.3

6.1

39.08

38.75

mmol/mol

0.66

1183

12586

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

2.22

2.38

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

6.27

2.37

1.0

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

485

1.46

2.37

1.7

2.0

2.57

2.88

g/l

1.75

445

(3038515) Glucose [Moles/volume] in Venous blood

217

0.41

2.31

5.6

2.4

7.01

7.35

mmol/l

—

206

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

133

1695

0.77

2.30

4.4

4.8

20.29

21.47

0.45

874

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

317

1.56

2.29

4.7

3.0

1.28

2.23

ratio

1.72

173

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

262

1.62

2.28

1.0

1.1

2.68

12.96

au/ml

—

(3036489) Thrombin time

507

1.44

2.25

1.4

1.7

20.80

20.87

0.03

443

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.16

2.25

1.2

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

338

2925

1.20

2.23

1.4

1.7

476.94

41879025.55

pmol/l

3.32

251

2438

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

614

0.63

2.23

1.3

1.6

1146.92

989.94

mu/l

0.43

490

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

233

1.65

2.21

1.4

1.2

33.61

19.79

u/l

0.71

200

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

297

1.56

2.18

1.3

1.6

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.34

2.18

1.0

1.1

0.03

0.02

u/ml

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

716

0.66

2.15

3.6

2.4

127.14

131.05

g/l

0.71

688

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

2.79

2.14

1.0

1.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

506

1.42

2.10

1.7

2.0

7.22

7.31

g/l

0.18

466

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

2.46

2.10

1.2

76.78

140.17

pmol/l

1.41

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

104

1352

0.75

2.10

1.8

1.7

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.51

2.05

1.0

1.2

—

(3020650) Glucose [Presence] in Urine

0.00

2.04

0.0

1.9

—

0.00

—

(1002224) Polysomnography panel

753

0.68

2.02

1.1

—

(3012441) Differential panel - Pleural fluid

1.97

2.00

1.4

1.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

258

0.46

1.99

1.4

1.7

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

163

1.73

1.99

2.1

40.11

28.43

u/ml

0.14

163

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

506

1.40

1.94

1.7

2.0

4.36

4.29

g/l

0.24

466

(3049717) Cytology report of Urine Cyto stain

405

1.45

1.94

2.8

2.5

—

(44806071) Cardiolipin IgM antibody measurement

3.76

1.93

1.0

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.45

1.93

1.4

3.7

296.83

164.86

umol/l

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

307

0.52

1.92

1.4

1.33

25.88

e6/l

—

211

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

143

1.76

1.89

1.3

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

220

1.60

1.89

1.2

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

612

0.66

1.88

3.5

2.4

1.09

1.15

0.31

606

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

3.19

1.88

1.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

159

1.71

1.86

1.5

2.0

4.16

6.01

umol/l

0.80

111

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

189

1575

1.23

1.85

1.8

1.7

1.44

1.37

0.87

156

1383

(3037756) Immunofixation for Serum or Plasma

245

1.56

1.85

2.8

1.5

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

1.99

1.85

1.1

293.12

242.17

mg/l

0.69

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.58

1.80

1.2

1.6

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

312

0.54

1.79

1.4

1.5

30.90

1767.14

e6/l

—

227

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

161

1.69

1.79

6.6

4.6

307.54

104.18

u/ml

—

(3025941) Bacteria identified in Stool by Culture

100

776

1.31

1.78

1.3

1.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

506

1.38

1.78

1.7

2.0

3.48

3.74

g/l

0.71

466

(3016018) Differential panel - Cerebral spinal fluid

169

1.67

1.77

1.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

1.90

1.75

1.6

1.5

1.42

1.18

promille

0.28

(3002032) Base excess in Venous blood by calculation

1057

0.75

1.72

5.2

2.7

1.54

1.89

mmol/l

0.35

920

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

179

1.63

1.70

1.3

1.5

1.56

4.44

ug/l

1.31

158

(3020682) Albumin/Creatinine [Ratio] in Urine

505

4604

1.14

1.68

4.4

4.0

9.95

6.90

mg/mmol

0.86

248

2714

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

3.17

1.66

2.8

3.7

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.17

1.66

1.0

1.3

—

(40758292) HTLV I+II Ab panel - Serum

3.17

1.66

1.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

157

1.67

1.66

1.7

1.5

20.32

22.22

ng/l

0.28

157

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

166

1383

1.22

1.65

2.3

1.9

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.15

1.61

1.1

1.5

89.83

76.43

nmol/24h

0.45

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

1.88

1.60

1.1

40.94

34.96

mg/l

0.36

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

222

1.54

1.60

1.1

1.0

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

206

1.56

1.60

1.2

1.1

197.50

257.09

u/ml

0.49

121

(3012544) pH of Venous blood

1101

0.77

1.60

5.1

2.7

7.37

7.38

1.31

559

(3012516) Albumin [Mass/volume] in Urine

500

4569

1.14

1.60

3.9

3.4

65.86

38.01

mg/l

1.58

249

2739

(3014148) Varicella zoster virus Ab [Titer] in Serum

159

1.65

1.59

1.3

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.01

1.59

1.2

—

(3027944) Amphetamines [Presence] in Urine

435

0.64

1.59

1.8

1.5

—

(3008037) Lactate [Moles/volume] in Venous blood

248

0.52

1.58

5.5

2.4

1.21

1.54

mmol/l

1.42

237

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

129

1.72

1.57

1.3

1.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

218

0.50

1.51

1.1

1.6

—

(4094501) Cardiovascular stress test using bicycle ergometer

416

0.64

1.49

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

281

0.57

1.49

2.6

1.8

17.89

6.87

pmol/l

0.61

281

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

110

1.74

1.43

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

625

1.29

1.40

1.5

1.6

35.12

11.09

u/ml

0.83

143

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

166

1.58

1.37

1.3

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

273

1.44

1.36

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

273

1.44

1.36

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1447

14194

1.19

1.35

5.8

5.1

4.84

4.79

mmol/l

0.98

1241

13343

(40758558) Short blood count panel - Blood

395

4327

0.88

1.34

9.7

5.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

144

1702

0.83

1.34

1.7

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

1.79

1.33

1.1

—

(3008295) Osmolality of Serum or Plasma

144

1.61

1.32

1.2

1.5

288.00

276.41

mosm/kgh2o

0.48

112

(40768806) Pleura Pathology biopsy report

1.77

1.29

1.6

1.7

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

256

2877

0.87

1.28

2.9

2.5

2.44

mmol/l

0.15

227

2605

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

1.94

1.27

1.1

2.8

114.42

122.24

0.22

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

186

1.51

1.27

1.1

1.48

g/l

0.02

170

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

115

1.66

1.25

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.23

1.24

1.0

1.3

—

(3045142) Bone marrow Pathology biopsy report

147

1.57

1.23

1.2

1.3

—

(21494434) Karyotype in Bone marrow

108

1.67

1.22

1.1

1.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

165

1419

1.18

1.22

1.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.64

1.21

2.0

2.4

—

(3009508) Creatinine [Moles/volume] in Urine

519

4824

1.11

1.21

3.8

3.3

6.93

7.20

mmol/l

0.66

367

4060

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

793

0.77

1.20

1.3

1.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

636

0.75

1.20

4.6

2.6

24.23

24.40

mmol/l

0.14

628

(3006184) Hemoglobin [Mass/volume] in Capillary blood

274

0.62

1.18

1.6

1.9

121.00

131.17

g/l

—

206

(3043238) Trisomy 21 risk [Likelihood] in Fetus

297

0.64

1.16

1.4

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

232

1.43

1.15

1.2

1.64

4.86

u/ml

1.37

(3005322) IgE [Units/volume] in Serum or Plasma

125

1056

1.20

1.14

1.3

135.70

170.07

u/ml

0.39

113

979

(3017704) Immunofixation for Urine

1.90

1.12

2.1

1.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.00

1.12

1.1

1.0

—

(3026008) Bacteria identified in Urine by Culture

464

4304

1.11

1.12

3.0

2.8

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1436

14114

1.16

1.10

6.0

5.0

1.57

1.54

mmol/l

1.33

1226

13182

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.96

1.09

1.1

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

175

1529

1.16

1.08

2.5

2.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

1.69

1.07

1.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

288

0.66

1.04

1.4

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.28

1.03

1.2

2.5

—

(3044290) Cell count panel - Cerebral spinal fluid

298

1.35

1.03

1.4

—

(40768795) Lymph node Pathology biopsy report

138

1.53

1.03

1.3

1.1

—

(3005033) Fetal Nuchal fold Thickness US

287

0.66

1.02

1.4

1.32

1.30

0.09

194

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

110

0.45

1.00

1.0

1.1

—

95.00

—

(3023410) Appearance of Cerebral spinal fluid

158

0.57

0.98

1.8

1.6

—

(3000285) Sodium [Moles/volume] in Blood

0.00

0.97

0.0

1.1

—

139.33

—

(21494890) Protein electrophoresis panel - 24 hour Urine

117

1.54

0.93

3.1

2.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

500

1.25

0.92

1.3

155.62

232.88

miu/ml

1.52

256

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

553

0.77

0.92

5.1

3.2

51.68

47.11

0.62

535

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

129

0.54

0.88

2.0

3.4

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

134

1172

1.16

0.86

2.2

2.1

72.63

71.99

ml/min/173m2

0.06

489

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

282

1.32

0.85

1.2

1.8

0.87

0.86

nmol/l

0.04

240

(3024891) Influenza virus A+B Ag [Presence] in Specimen

371

1.27

0.84

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.94

0.84

1.8

3.7

—

(3045788) Cell count panel - Pleural fluid

1.57

0.84

1.3

1.4

—

(3003181) Sodium [Moles/volume] in Urine

222

1.36

0.84

1.4

65.75

63.36

mmol/l

0.11

177

(40768800) Prostate Pathology biopsy report

139

0.57

0.83

1.1

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

214

0.65

0.83

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

228

2072

1.12

0.82

6.3

5.7

1.99

2.26

ug/l

0.72

174

1837

(3018405) Lactate [Moles/volume] in Arterial blood

409

1.26

0.81

3.5

3.2

1.11

1.35

mmol/l

1.73

404

(3001019) Free T4 and TSH panel - Serum or Plasma

999

0.84

0.81

1.9

1.8

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

1.71

0.80

1.6

2.0

60.25

49.67

ug/l

—

(3002179) Metamyelocytes/Leukocytes in Blood

130

1142

1.15

0.79

3.3

4.2

0.88

0.62

0.88

282

(21494755) Public health laboratory ask at order entry panel

123

1401

0.87

0.79

1.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

148

0.61

0.79

1.1

1.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

156

1.42

0.79

1.0

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

575

1.21

0.78

2.4

2.3

9.53

12.35

nmol/l

1.66

512

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

114

1300

0.87

0.76

3.1

2.2

29.51

37.81

u/l

1.66

100

1088

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

1.65

0.75

1.2

1.3

9.00

9.30

u/l

0.07

(3020891) Body temperature

588

1.20

0.74

4.2

4.0

36.90

36.91

°c

0.04

581

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

368

0.76

0.73

1.4

1.5

75.33

59.71

ug/l

0.71

296

(3028300) Cannabinoids [Presence] in Urine

445

0.78

0.72

2.6

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

217

0.69

0.70

1.3

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

212

1.33

0.70

1.3

1.5

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

1.55

0.69

1.2

1.4

11.22

11.92

u/l

—

(3000764) Benzodiazepines [Presence] in Urine

442

0.79

0.69

2.6

1.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

529

1.20

0.68

1.7

1.6

0.39

0.34

mg/l

0.25

234

(3016228) CD19 cells/cells in Blood

1.67

0.68

1.4

2.1

14.43

7.93

—

(3027008) Opiates [Presence] in Urine

441

0.79

0.68

2.6

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

1.49

0.66

1.7

1.5

5.44

6.43

u/l

0.16

(3025577) Chromium [Mass/volume] in Blood

1.54

0.65

1.9

2.2

1.10

2.47

ug/l

—

(21494814) CD8 cells/Lymphocytes in Specimen

1.59

0.65

1.3

2.1

24.86

26.59

—

(3025130) Human papilloma virus identified in Specimen

326

0.76

0.64

2.0

1.9

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

265

2467

1.09

0.61

1.9

1.8

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.67

0.61

1.4

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.57

0.60

1.9

3.2

1.75

1.65

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.00

0.60

0.0

2.5

—

0.86

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

124

1112

1.12

0.60

1.2

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

183

1.32

0.59

1.1

1.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

529

1.18

0.59

1.9

2.0

405.11

5123.65

u/l

2.98

214

(3038177) Helicobacter pylori Ab [Presence] in Serum

254

0.75

0.59

1.2

—

(4198724) Urine methamphetamine measurement

1.72

0.57

1.0

1.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

408

0.80

0.57

1.4

1.3

—

(3016879) Cocaine [Presence] in Urine

408

0.80

0.57

2.7

1.5

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.46

0.56

1.4

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.46

0.56

1.4

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.46

0.56

1.4

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.46

0.56

1.4

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

159

1.32

0.55

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.45

0.53

1.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.43

0.53

1.5

1.3

58.60

90.21

ng/l

2.48

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

0.62

0.52

1.7

1.1

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

455

4752

0.94

0.52

2.6

2.9

33.07

30.74

u/l

0.59

404

4496

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

978

0.88

0.51

2.2

1.9

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.50

0.51

2.2

1.5

6.97

8.81

ug/l

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

542

0.84

0.51

1.1

0.52

0.61

ratio

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

191

0.73

0.51

1.1

1.3

—

nmol/l

—

(37208534) Antinuclear antibody arbitrary concentration in serum

1.47

0.50

1.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1449

14355

1.09

0.50

6.2

5.8

2.81

mmol/l

0.11

1234

13433

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

136

1.33

0.49

1.1

—

(3017181) Myelocytes/Leukocytes in Blood

131

1197

1.10

0.48

2.8

4.3

1.15

0.83

0.85

303

(3024928) Oxygen saturation in Venous blood

278

0.79

0.48

2.1

2.2

52.90

60.34

0.96

269

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

1.41

0.47

1.3

1.5

—

(3023419) Bacteria identified in Sputum by Culture

152

0.72

0.44

2.0

2.5

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.04

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.41

0.0

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.41

0.0

1.3

—

6.02

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.00

—

(3034092) Cytoplasmic Ig cells/cells in Blood

0.00

0.41

0.0

9.6

—

0.19

—

(3052851) Hemolysis interference index of Serum or Plasma

342

1.17

0.41

2.2

3.1

2.33

1.67

index

0.21

155

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

141

1306

1.09

0.41

1.8

1.7

3.44

3.49

mmol/l

0.22

912

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

2.9

—

6.88

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

1.31

0.39

1.8

1.7

710.37

1067.20

u/ml

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

214

1.22

0.39

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

214

1.22

0.39

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.39

0.0

5.1

—

8.08

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.00

0.39

0.0

1.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.35

0.38

2.7

1.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

252

1.19

0.38

1.1

3.06

3.22

u/ml

0.03

123

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

411

1.15

0.37

2.7

3.3

155.54

687.34

u/ml

0.77

349

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

114

1234

0.92

0.37

3.9

3.3

0.70

0.76

ug/l

0.70

825

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

0.65

0.35

1.0

1.2

6.80

9.99

mm/h

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1024

0.91

0.35

1.6

1.4

29.23

30.03

iu/l

0.09

888

(3050129) First trimester maternal screen panel - Serum or Plasma

415

1.14

0.34

1.3

1.4

—

(3021440) Promyelocytes/Leukocytes in Blood

124

1157

1.08

0.32

2.8

4.4

0.11

0.01

260

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.35

0.32

1.3

1.1

1201.70

1617.12

miu/ml

—

(3026389) Candida sp identified in Specimen by Organism specific culture

192

1.20

0.32

1.6

1.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

145

1542

0.93

0.32

2.8

2.5

6.91

6.31

umol/l

0.21

124

1351

(3047189) Immunofixation for 24 hour Urine

1.35

0.31

3.7

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

202

1.19

0.31

1.0

1.1

—

0.36

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

347

0.86

0.31

1.4

0.96

ratio

0.01

211

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

347

0.86

0.31

1.4

1.23

1.10

ratio

0.43

211

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

347

0.86

0.31

1.4

1.26

1.18

ratio

0.15

211

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

221

1.18

0.30

1.1

1.2

1.00

2763.73

iu/ml

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

346

0.86

0.30

1.4

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

173

1640

1.06

0.29

6.1

6.4

105.40

104.41

mmol/l

2.28

173

1640

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

432

1.11

0.27

2.0

10.15

10.37

g/l

0.12

390

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

177

1.19

0.27

1.2

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

343

0.87

0.27

2.8

1.5

—

(44813793) Dust mix specific IgE antibody measurement

117

0.77

0.27

1.1

1.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

128

0.78

0.27

1.2

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.70

0.26

1.2

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

1.30

0.26

1.2

1.4

153.90

129.05

nmol/l

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.23

0.25

1.1

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

202

0.84

0.25

1.9

1.5

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

126

0.79

0.24

1.6

1.4

1.54

1.41

nmol/l

—

112

(3008898) HLA-B27 [Presence]

571

1.09

0.24

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

246

1.14

0.23

1.1

0.32

1.24

u/ml

1.07

100

(3000991) Gas panel - Venous blood

105

990

1.06

0.23

7.5

7.8

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

181

1.16

0.22

1.1

0.02

0.13

u/ml

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

191

1835

1.05

0.22

1.8

28.66

29.16

0.73

178

1787

(3019832) Treponema pallidum Ab [Presence] in Serum

125

1314

0.95

0.21

1.6

1.7

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

771

0.93

0.21

1.3

1.4

—

(4024509) Urine culture

633

1.08

0.21

2.2

1.9

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

0.00

0.21

0.0

1.4

—

18.00

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.00

—

(3042951) Complement C1q Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

26.88

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.1

—

8.07

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.8

—

53.18

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.21

0.0

1.4

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

0.00

0.21

0.0

1.2

—

25.43

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.16

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

126

1.19

0.21

1.1

—

(3034426) Prothrombin time (PT)

1.16

0.21

1.6

1.3

26.40

27.93

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.02

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.21

0.0

1.1

—

(3015736) pH of Urine

601

6115

0.97

0.20

3.4

3.3

6.26

6.23

0.33

315

3415

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

2.60

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.20

0.0

1.0

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

144

0.83

0.20

1.3

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

127

1.18

0.19

1.3

1.5

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

133

0.83

0.19

1.3

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

807

0.94

0.19

2.0

1.8

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

280

0.89

0.18

2.8

3.1

25.42

23.68

mg/l

0.14

183

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

181

1747

1.04

0.18

2.2

2.0

3.21

3.34

ratio

0.89

142

1341

(3011985) Renin [Units/volume] in Plasma

223

1.12

0.18

1.4

36.74

77.92

mu/l

0.85

199

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

168

1620

1.04

0.18

1.4

—

(3051651) Icteric interference index of Serum or Plasma

1.17

0.17

4.1

3.0

1.29

0.70

index

—

(3023511) Choriogonadotropin [Units/volume] in Urine

291

1.10

0.17

1.3

1.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.14

0.16

1.1

1.3

125.13

168.70

mmol/24h

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

235

0.89

0.16

1.1

1.3

0.60

8.13

nmol/l

0.50

227

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

312

1.09

0.16

1.3

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

140

0.86

0.15

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

129

0.85

0.14

1.5

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

169

1.13

0.14

5.5

6.1

395.86

362.26

umol/l

0.54

148

(44790049) Parainfluenza type 3 nucleic acid detection

141

1.14

0.14

1.6

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

141

1.14

0.14

1.6

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

141

1.14

0.14

1.6

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

141

1.14

0.14

1.6

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

668

1.05

0.12

1.5

1.2

0.30

1.27

u/ml

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.18

0.12

1.0

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

137

0.87

0.12

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

137

0.87

0.12

1.3

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

201

1.10

0.11

1.1

3.29

4.34

u/ml

—

(3018333) Ribosomal P Ab [Presence] in Serum

126

0.87

0.11

1.3

1.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

301

0.93

0.11

4.1

2.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

212

1.09

0.10

1.1

0.71

2.44

u/ml

1.74

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

193

1.09

0.10

1.2

170.20

157.76

au/ml

—

(3039443) Prostate specific Ag panel - Serum or Plasma

114

0.88

0.09

2.4

1.7

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

302

1.06

0.08

1.2

1.1

1.27

1.78

u/ml

0.31

155

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.03

0.08

1.0

1.2

—

1738.51

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

0.84

0.07

3.8

2.2

—

(4062490) Immunoglobulin typing, IgG

137

1.10

0.07

1.3

1.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

294

1.06

0.07

1.9

2.3

128.84

113.93

ug/min

0.09

175

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.84

0.07

1.1

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

265

0.94

0.07

1.3

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

417

0.96

0.06

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

327

3236

1.01

0.06

1.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

376

0.96

0.06

2.2

2.1

0.00

g/l

-0.00

333

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

100

1.10

0.05

1.0

784.17

740.02

ng/l

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

100

1.10

0.05

1.0

319.20

330.37

ng/l

—

(3025159) Blasts/Leukocytes in Blood

115

1170

0.98

0.05

3.7

4.6

0.08

0.07

0.10

245

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

384

0.96

0.05

2.2

2.1

0.00

g/l

0.50

347

(3028707) Methadone [Presence] in Urine by Screen method

189

1.06

0.04

3.6

1.7

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

211

0.95

0.04

1.2

1.3

379.86

350.21

pmol/l

0.07

180

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

411

0.97

0.03

1.2

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

479

1.02

0.03

1.9

2.0

9.54

4.39

iu/l

0.94

199

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

102

1.08

0.03

1.0

38.84

45.24

ng/l

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

410

0.97

0.02

1.2

1.1

—

(3029937) Albumin [Presence] in Urine by Test strip

424

4254

1.00

0.02

3.5

3.9

0.02

0.01

estimate

0.29

1414

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

286

2870

1.00

0.01

1.4

1.5

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

1.04

0.00

3.7

2.3

1398.90

1141.23

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

226

1.02

0.00

1.2

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

128

1.02

0.00

1.5

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

239

1.00

0.00

1.5

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

235

1.02

0.00

1.2

1.1

0.38

0.86

u/ml

1.09

106

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

235

1.02

0.00

1.3

1.4

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.0

1.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.97

0.00

1.5

1.8

8.77

8.93

mmol/l

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

0.00

0.0

9.5

—

7.88

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

8.74

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.0

4.8

—

54.38

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.97

0.00

1.4

1.1

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

37.78

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.01

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

22.21

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

0.02

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3026480) Teichoate Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

37.26

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

285.67

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

0.97

-0.00

1.1

1.8

3.56

3.70

nmol/l

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

-0.00

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

12.0

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

0.00

-0.00

0.0

5.4

—

24.71

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

1.00

—

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

1.43

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

3240.00

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.91

-0.00

1.0

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

0.45

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(4212803) Bone marrow aspirate examination

0.00

-0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

-0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.87

-0.00

1.3

1.4

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

0.00

-0.00

0.0

1.8

—

0.07

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.02

—

(3024263) Appearance of Synovial fluid

0.98

-0.00

1.8

1.7

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: Z21_FOLLOW__CARE_INVOLVI_PLASTIC_SURGE – Follow-up care involving plastic surgery

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Follow-up care involving plastic surgery

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Follow-up care involving plastic surgery (Z21_FOLLOW__CARE_INVOLVI_PLASTIC_SURGE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints